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ABSTRACT 
 
Study and Characterization of a Novel Small Heat Shock Protein from Babesia. 
 
(August 2006) 
 
Kenneth Harris Carson, B.S., The University of Texas at Tyler 
 
Chair of Advisory Committee:  Dr. Allison C. Rice-Ficht 
 
 
Many proteins can easily attain a non-native fold and be of no use or even a 
detriment to the host.  The host cell has a myriad of molecules dedicated to assisting 
nascent and existing proteins in folding properly and maintaining the native fold.  Of 
these molecular chaperones, the small Heat Shock Proteins (sHSP’s) are an important 
group and worthy of study.  The sHSP’s are a diverse group of proteins that have in 
common an α-crystallin domain and generally display a chaperone activity.  A sHSP 
(HSP20) isolated from the cattle parasite Babesia bovis has similar activities, and limited 
sequence homology to other α-crystallins. The gene encoding HSP20 was cloned into an 
expression system where the gene product was induced and purified for study.  It was 
shown that HSP20 inhibits thermally induced aggregation of alcohol dehydrogenase at 
equimolar ratios.  HSP20 was also used to significantly reduce amyloid formation of the 
β-Amyloid (1-40) Peptide in vitro at the sub-stoichiometric ratio of 1:10.  A study of the 
oligomeric forms of HSP20 using size exclusion chromatography and gel electrophoresis 
revealed a broad range of multimers present in solution.  The distribution of oligomers 
was affected by altering the solution conditions and concentration of the protein.  The 
domains responsible for multimerization of HSP20 were mapped via sequence 
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homology with known α-crystallins.  These regions correspond to 12 carboxy-terminal 
amino acids and 50 amino-terminal amino acids.  Truncated versions of HSP20 lacking 
these proposed oligomerization domains were created using PCR of the original gene 
and cloning into an expression vector as before.  Using size exclusion chromatography, 
gel electrophoresis and analytical centrifugation, we show that the deleted domains alter 
the multimeric population of the protein in solution.  The carboxy-terminal domain has a 
slight effect on multimerization while the amino-terminal deletion results in a drastic 
reduction in any multimers above a dimer under the conditions tested.  Despite this 
drastic change in the multimerization of HSP20, there were no changes in the activities 
observed when compared to the full-length form.  From this we conclude that the regions 
responsible for multimerization play little role in the observed activities of HSP20.  
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CHAPTER I 
INTRODUCTION 
The ability of a protein to attain a native or active folded state is not a trivial one.  
The process by which a protein folds into its native form is crucial, but often is not 
spontaneous.  Molecular crowding, salt concentrations, reducing and oxidizing 
conditions and the high concentration of other proteins may all contribute to a protein 
folding incorrectly (Figure 1). Non-native forms of a protein are often stabilized by 
interactions between partially folded intermediates and other molecules.  Regions of a  
protein made accessible when in the non-native form could also lead to the stabilization 
of an inactive form.  In some cases, an amyloidogenic form of a protein is stabilized.  
This leads to amyloid fibril formation which involves the conversion of a normally 
soluble protein or peptide into an insoluble aggregate high in beta sheet structure (Figure 
1).  
Proteins that are not folded correctly do not perform their functions properly. 
They may even be detrimental to the health of the host organism and must be disposed 
of by the cell.  Therefore, the cell has devised ways to combat the tendency of proteins to 
fold improperly.   Molecular chaperones are required in many cases to ensure the proper 
folding of proteins (1).   
The term “molecular chaperone” describes a wide range of molecules recruited 
by the host cell to assist in the proper folding of nascent and existing proteins.   
 
This dissertation follows the style of Biochemistry. 
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This very important class of molecules has been shown to assist in protein folding, 
translocation and assembly of active protein complexes within cells. 
An Overview of Molecular Chaperones 
As nascent chains are translated, they are not allowed to fold due to the confined 
space of the ribosome.  Also, many native folds cannot be attained until a large majority 
or the entire protein is translated.  During this time, many regions of the protein are 
exposed to an environment that could lead to stabilization of a non-native folded form of 
Native form Unfolded formIntermediate
Aggregate
Amyloid precursorAmyloid
Figure 1  Overview of possible native and non-native protein states in the cell.  
Native proteins are in equilibrium with unfolded intermediates.  Under certain 
conditions, those intermediate forms are stabilized leading to interactions between 
regions of the protein not normally accessible.  This could result in aggregation.  An 
amyloidogenic form of the protein could also be stabilized leading to amyloid fibril 
formation 
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the protein (misfolding).  This propensity to misfold is often exacerbated by  other 
nascent chains being translated at the same time and in very close proximity that are 
themselves partially or completely unfolded (2).   Both prokaryotes and eukaryotes have 
chaperones to assist nascent chains with proper folding.  In prokaryotes, proteins 
needing assistance in folding often interact with dnaJ and dnaK.  Proper folding is 
attained by a series of ATP-dependent bindings and dissociations.  If additional folding 
is needed, the nascent protein can interact with GroEL and GroES.  Here, the nascent 
chain is enclosed by the chaperones and sequestered from other molecules while it 
attains the native fold.  Again, ATP is needed to enclose the protein within the “shell” of 
chaperones (2).  A similar system is in place in eukaryotes (TRiC).  Here, the nascent 
chain interacts with HSP-40, -70, and -90 (as proteins interact with dnaJ and K in 
prokaryotes) as it is translated from the ribosome. TRiC is a complex similar to that of 
GroEL and GroES allowing the protein to fold in a protected environment (2). 
Many chaperones are constitutively expressed; however, the environment of a 
cell can change causing stress.  During times of physiologic stress on an organism, some 
chaperones are upregulated.  This group of chaperones is known as the Heat Shock 
Proteins (HSP).  Members of this large group of proteins are upregulated by the host in 
response to various stresses such as temperature change, pH, and oxidative stress.  The 
family of chaperones known as small Heat Shock Proteins (sHSP’s) are a large and 
functionally diverse group that are the subject of a great deal of study (3).  
The sHSP’s are a large set of chaperones ranging from 12 to 43 kDa in size.  
They are phylogenetically diverse and are active in many areas of the cell (2).   These 
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molecules assist in maintaining the native folds of proteins in an ATP-independent 
manner until other chaperone machinery can refold the proteins.  These sHSP’s typically 
have the ability to assemble into dynamic oligomers ranging in size form 300 kDa to 1 
MDa and above (4, 5).  The chaperone activity generally requires a disassembly of these 
large multimeric complexes (2).  However, it is not completely clear what role, if any, 
the multimerization of the sHSP’s plays in their activity. 
The major structural motif of the sHSP’s is the α-crystallin domain.  This ~95 
amino acid region is characterized by many β-strands arranged in a β sandwich that is 
thought to be the primary site of interaction with unfolded proteins.  It is also thought to 
be responsible for dimer formation.  An amino terminal region, often unstructured and of 
variable length, is thought to be responsible for higher-order structures and modulation 
of some chaperone activity.  A carboxy-terminal region (about 12 amino acids in length) 
is thought to be responsible for interactions between smaller multimers leading to 
assemblies larger than dimers as well as modulation of chaperone activity (5, 6).  
Multimeric assembly and chaperone activity appear to be linked as the multimeric state 
of the protein seems to vary with temperature (1, 2, 4-9).  Thus, affecting the multimeric 
assembly may by default affect the chaperone activity. 
The main structural motif of the sHSP’s is the α-crystallin domain.  The term 
"crystallin" refers to the major structural proteins in the eye lens of vertebrates that are 
responsible for its refractive power (10). The crystallins make up over 90% of the total 
mass of the lens. Of these proteins, approximately one-third is alpha-crystallin. There are 
two forms of the protein that are closely related and share a high degree of sequence 
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homology: αA- and αB-crystallin.  The remaining two-thirds are two related crystallins: 
β and γ. These proteins form an oligomeric distribution in solution typically ranging in 
size from 300 kDa to over 1 MDa, while the molecular weight of the monomeric protein 
is about 20 kDa (10).  Circular dichroism spectroscopy (CD) studies predict the beta-
pleated sheet form dominates the secondary structure of the α-crystallins (6, 9-11). 
  Crystallins have been found in many other cells of the human body (as well as 
other organisms) though never in concentrations approaching that found in the lens of 
the eye (10).   The presence of α-crystallins in the lens lead to research of the proteins’ 
function in vivo (10-12).  Horwitz and others concluded that the protein plays a vital role 
in the continued clarity of the lens. The subsequent clouding and cataract formation in 
older patients is attributed to decreasing α-crystallin activity with age. Indeed, mutations 
in α-crystallin result in cataract formation early in the patient's life (6, 10). This is 
compelling evidence that the function of the protein in the lens is to keep other proteins 
from aggregating.  A point mutation (R120G) in α-B-crystallin results in loss of function 
of the gene product. The molecular weight of the oligomer of the mutant is very different 
from wild type (10).  While wild type α-B-crystallin has a multimeric molecular weight 
of approximately 540 kDa, the (R120G) mutant forms much more irregularly-shaped 
assemblies with an average molecular weight of about 850 kDa (10). Patients with this 
mutation suffer from Desmin-related myopathies (DRM) which are characterized by 
accumulation of aggregates of desmin. Patients suffer from various muscle problems as 
well as the development of cataracts. Many crystallins share homology with small heat-
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shock proteins. α-Crystallin has been implicated in the survival of cells subjected to heat 
shock or oxidative stresses by conferring increased stability on actin fibers (8).   
Several sHSP’s have been studied.  Kim et al. have performed extensive studies 
on a sHSP from the hyperthermophilic archeon Methanococcus jannaschii designated 
HSP 16.5 (13-17).  van Montfort et al. studied a sHSP from wheat  termed 16.9 (6).  
Both of these proteins have been crystallized and models of their multimeric assembly 
have been proposed (6, 14, 16).  Unlike other α-crystallins, these proteins seem to have a 
more distinct multimeric structure, thus facilitating their crystallization. 
Horwitz was one of the first to show that α-crystallin acted as a molecular 
chaperone (10, 11).  He showed that α-crystallin purified from the lenses of bovine eyes 
was as effective as GroEL in suppression of aggregation of α-glucosidase at elevated 
temperature (11).  Horwitz went on to show that α-crystallin could inhibit aggregation of 
several enzymes including glutathione S-transferase, citrate synthase and horse liver 
alcohol dehydrogenase at elevated temperatures (11). The suppression of aggregation of 
other important lens proteins (β-crystallin) by α-crystallin was also shown by Horwitz 
(11).  The two forms of the chaperone (αA- and αB-crystallin) were both effective in 
preventing thermal aggregation of the substrates tested.  It is important to note, that this 
inhibition of aggregation (measured by apparent light scattering) required stoichiometric 
amounts of the chaperone though it was (and still is) thought to exist as a large multimer.  
Horwitz concludes his early work with a discussion on the need to know and understand 
the active form of the chaperone (11).  This is still a subject of much debate as more 
sHSP’s are being discovered with different multimeric assemblies.  
7 
 
The 16.5 kDa sHSP from M. jannaschii shares 20.7% sequence identity with 
human αA-crystallin and 31.4% identity with a rice sHSP (HSP16.9).  However, unlike 
other sHSP’s that form a population range of multimeric species in solution, M. 
jannaschii HSP16.5 forms a stable oligomer of 24 subunits.  This structure is visible 
using electron microscopy and is approximately 15-20 nm in diameter (9).  Kim showed 
that the protein could be used to stabilize a wide range of proteins against thermal 
degradation. It is important to note that the researchers observed a substrate-dependent 
range of molar ratios of substrate to sHSP in order to inhibit aggregation.  This was 
thought to be a result of the different temperatures at which the substrate began to 
denature and the subsequent activity of the sHSP at that temperature (9).  
 The proposed structure of M. jannaschii HSP16.5 is a hollow spherical complex 
of 24 monomers.  The α-crystallin domain of each monomer forms a β sandwich that 
incorporates one of the strands from a neighboring molecule creating a dimer.  The 
structure has several holes or “windows” opening to a core (14).  The amino termini of 
all monomers are highly disordered while the carboxy terminus of each monomer is 
highly ordered.  The crystal structure reveals many points of contact between interacting 
monomers with hydrogen bonds, ionic and hydrophobic interactions all playing roles in 
the assembly of the oligomer (14).  Because of the location of these contacts, it was 
theorized that the dimer is the “building block of the sphere”.  The authors also 
concluded that the disordered amino termini were inside the sphere (14).  They go on to 
conclude that the interior of the structure could be used to sequester RNA or proteins 
during times of environmental stress or the structure itself could simply be a storage 
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mechanism for the protein until the host is exposed to a stress and the protein becomes 
active (14).  Later research by the same group showed that the secondary structure of the 
protein changes very little at high temperatures (80°C).  It is at this high temperature that 
the protein interacts with the substrate single-chain monelin (17).  Through a number of 
approaches, the researchers found that the substrate binds to the outside of the HSP 16.5 
sphere and is thus not capable of forming aggregates with itself in vitro.   Finally, it was 
found by Kim et al. that the unstructured amino region of the protein “had no structural 
role”, but that it might play a role in the kinetics of oligomerization by acting as a 
nucleation site or condensing area for monomers (17). 
A second sHSP from wheat (HSP 16.9) was crystallized by van Montfort et al 
(6).  The quaternary structure is made up of two rings composed of 6 monomers each 
resulting in a dodecamer.  Again, the dimer is a result of interactions between the α-
crystallin domains of two monomers.  The researchers were able to show through their 
crystal structure that the carboxy terminus appeared to be involved in interactions 
between sets of dimers on different disks in some cases and to dimers in the same disk at 
other times (6).  The authors went on to show that the N-terminal regions are structured 
in half of the monomers.  The structured arms from two adjacent hexameric disks 
interact with one another to form a helical domain on the inside of the dodecamer.  This 
creates a more compact multimer and adds rigidity to the whole structure (6).  The N-
and C- termini were shown to be of great importance to oligomeric assembly of HSP 
16.9.  van Montfort et al show that the sHSP from wheat disassembles at higher 
temperatures as evidenced by size exclusion chromatography (6).  Because of this 
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disassembly at elevated temperatures, van Montfort proposes that unfolded proteins 
interact with the α-crystallin domain of HSP16.9 in an active “subassembly” form. 
At first glance, the two proteins discussed above have limited similarity.  
However, structurally they have some common features.  The fold of the α-crystallin 
domain of wheat HSP16.9 is very similar to that reported for the M. jannaschii HSP16.5, 
though sequence homology is relatively low between the two proteins (1, 6).  A common 
motif of IXI/V is seen in the C-terminal extensions of both proteins as well (1, 6). 
Another conserved residue found in HSP 16.9 is Arg 108.  This residue is equivalent to 
residue 120 in human αA-crystallin.  Arg107 is the equivalent residue in M. jannaschii 
(1).  As stated earlier, mutations at this site in the human homolog causes an apparent 
loss of function. Finally, a conserved quaternary interaction involving the binding of the 
C-terminal region into a groove of the α-crystallin domain is seen in both crystal 
structures.  Despite these structural similarities, the quaternary structure is quite different 
(6). 
From all the research performed on sHSP’s, many groups have proposed models 
of how these molecules function in the hierarchy of chaperones within the cell.  Figure 2 
illustrates a possible scheme of protection against unwanted aggregation and where the 
α-crystallin sHSP’s might function within it.  Here, the sHSP is represented as a 
multimer that acts as a sink for intermediate and unfolded forms of the protein.  These 
proteins are not allowed to interact with other molecules that might lead to aggregation.  
Instead, they are sequestered from these undesirable interactions and are thus allowed to 
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return to their native form independently or with the assistance of the active refolders 
such as dnaK or GroEL.  
An Overview of Amyloid Fibril Formation and the Amyloidoses 
          Though aggregation might often seem to be an unordered state of a protein, this is not 
always the case.  A specialized form of protein aggregation seen in a group of  
 
 
 
 
Unfolded formIntermediate
Active Folders (Dna-k, GroEL)
Native form Complex with
α-Crystallin Multimer
Figure 2  Possible role of α-crystallin in maintaining native protein folds.  The 
crystallin is represented as a multimer.  Unfolded and intermediate forms of the 
protein interact with regions of the crystallin multimer and are sequestered from 
other interactions that might lead to aggregation.  The protein is then allowed to 
refold or is assisted by the active folders represented here by dnaK and GroEL 
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disorders is termed amyloid and is very highly ordered.  Amyloid was first observed by 
Rudolph Virchow in 1854 through staining the cerebral copora amylacae with iodine.  
He noted a strange macroscopic appearance that stained blue.  He concluded it to be 
starch and named it amyloid (from the Latin amylum meaning starch) (18).  Later 
research sparked debate as to whether or not the deposits were fat or carbohydrate in 
nature.  Finally, Friedreich and Kekule showed amyloid was in fact proteinaceous and 
contained no carbohydrate (18). 
Researchers later utilized the amyloid-specific dye Congo red to identify 
amyloid.  This planar aromatic dye shows altered spectroscopic properties when in the 
presence of amyloid.  The birefringence observed when amyloid was stained with Congo 
red indicated an ordered structure and has since been adopted as a criterion of amyloid 
(18).  Later, electron microscopic studies of amyloid tissues were performed.  It was 
immediately recognized that many amyloid forms showed similar structure in tissues 
characterized by bundles of straight rigid fibrils.  This structure became the second 
criterion for the definition of amyloid (18).  The amyloid fold is characterized by 
monomers of beta strands oriented perpendicular to the axis of the fibril.  It is these 
stacked beta strands that appear as rigid fibrils using electron microcopy (18). 
There are several possible models for amyloid fiber formation.  The simplest 
possible mechanism that explains fibril formation is the nucleation model (19).  This 
model was chosen based on the observation of a lag phase in fibril development 
followed by a much more rapid elongation phase.  This lag phase is reported to consist 
of a rate-limiting nucleation step that produces an organized amyloidogenic nucleus of 
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monomeric proteins/peptides (19).  Once this forms, the elongation into fibrils is rapid.  
Other processes of molecular assembly in vivo are also characterized by this nucleation-
dependent pathway such as viral coat assembly, microtubule formation and flagellum 
formation (19).  These processes are all characterized by a slow nucleation phase where 
a series of slow rearrangements occur eventually resulting in the formation of a stable 
nucleus of ordered monomers.  This nucleus then acts as a seed allowing further 
assembly to proceed rapidly.  Finally, the large polymers or multimeric assembly 
reaches equilibrium with the monomer (19).  Because of this nucleation step, a “critical 
concentration” of monomer must be observed before fibrils begin to form and fibrils 
only grow as long as this minimum concentration of monomer is maintained.  The slow 
nucleation phase results in a “lag time” during which the supersaturated solution remains 
kinetically soluble.  The length of this lag phase is dependant on buffer conditions such 
as pH, temperature, and salt concentrations.  It is also dependant upon protein 
concentration as well as the presence of other proteins in solution (19).  Further proof of 
the nucleation-dependant model stems from seeding experiments.  Here, a pre-formed 
fibril is added to the solution.  Because the necessary nucleus is already formed, fibril 
assembly can continue at a rapid pace (as long as the critical concentration of monomer 
is maintained).  Indeed, researchers have seen the disappearance of the lag phase by the 
addition of seed polymers in relatively small amounts (~5% by moles in some cases.) 
(19).  Other theories of amyloid formation still use the nucleation model.  They differ in 
how the monomer is converted to an amyloidogenic form, and in the nature of the rate-
limiting step (20).  In the “templated assembly” model, the amyloid polymer acts as a 
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template that allows for conversion of soluble monomers.  In the “monomer-directed 
conversion” model, the soluble monomers convert to amyloidogenic forms 
spontaneously and thus drive nucleation by their conversion (20).  In another model 
proposed, the soluble and amyloidogenic species are in equilibrium in solution.  Here, 
the rate-limiting step is the chance convergence of those amyloidogenic species in 
solution and the subsequent formation of a nucleus (20).  In any case, the nucleation 
model is the simplest explanation for not only the results of in vitro experiments, but the 
in vivo sequence of events in which symptoms of amyloid diseases take a very long time 
to manifest.  The nucleation model is shown in the Figure 3. 
The amyloidoses have garnered much attention in research recently.  Over 
sixteen different types of amyloid proteins have been observed in amyloid deposits in 
clinical diseases (21).  Amyloid fibril formation is observed in cases of Diabetes 
mellitus, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, the 
Spongiform Encephalopathies such as Kuru, Mad Cow Disease, Scrapie, Creutzfeldt 
Jacob Disease and Fatal Familial Insomnia. 
Alzheimer’s disease is characterized by fibrillar protein deposits both intra-and 
extracellular to neurons in the brain.  These highly-organized protein aggregates are 
termed amyloid plaques.  These plaques consist mainly of a 39 to 43 amino acid 
fragment of the Amyloid Precursor Protein (APP) (22).  This peptide (A peptide) is 
arguably the most studied of the amyloid-forming proteins.  The peptide is the result of 
an alternate proteolysis of APP.  There at least four membrane-bound APP’s produced 
from alternative splicing of the APP gene (23). 
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The APP proteins undergo a series of proteolytic cleavage events that could 
result in the production of the amyloid-forming peptide (23).  If cleaved by -secretase, 
APP is processed normally.  However, cleavage by - or -secretase results in 
production of the highly amyloidogenic peptide.  The A peptide is secreted where it 
interferes with cholinergic neuron function both pre-and post-synaptically (24).  It is 
thought that this contributes to the eventual loss of neurons and the onset of symptoms 
+ +
A
B
B
C
Lag 
Phase
Nucleation
Seeded 
Growth
Figure 3  Proposed nucleation model of amyloid fibril formation.  A) 
Spontaneous conversion from native to amyloidogenic form.  B) Directed 
conversion (recruitment) of native form to amyloidogenic form by another 
amyloid form.   C)  Stable nucleus forms resulting in rapid recruitment and 
growth of fibril.  Adapted from Harper et al. (19). 
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such as dementia and memory loss.  It has been shown in vitro that synthetic peptides of 
as few as 14 amino acids from the sequence of A form amyloid fibrils spontaneously 
(23). 
The Spongiform Encephalopathies (Mad cow Disease, Scrapie in sheep, and it’s 
human forms Creutzfeldt Jacob-CJD, Kuru, and Gerstmann-Sträussler-Scheinker 
syndrome-GSS) are other neurological diseases associated with amyloid fibril formation.  
Here, the prion (PrP) protein undergoes a structural change from its normal soluble form 
(PrPC) to a structure containing much more beta sheet secondary structure (PrPSC) that is 
proteolytically stable and accumulates in the brain.  There are point mutations associated 
with this PrPSC; however, these mutations are not always seen (19).  This proteolytically 
stable structure continues to aggregate and form plaques eventually leading to cell death.  
Neurons are destroyed at a rapid rate.  Upon necropsy, the brains have a sponge-like 
appearance where huge areas of neurons have been destroyed leaving holes.  PrPSC has 
been shown in the laboratory to recruit wild type soluble PrP to form more copies of this 
alternate structure thus propagating the disease (19). 
Because amyloid formation is thought to be a type of aggregation, researchers 
have explored the possibility that sHSP’s can inhibit this aggregation as they inhibit 
aggregation of other proteins in solution. In fact, it has been reported that there is an 
increase in the level of sHSP’s and α-crystallins in the brains of patients diagnosed with 
Alzheimer’s (25, 26).  However, experimental efforts to prove inhibition of 
amyloidogenesis by α-crystallins have produced mixed results.  Some have reported that 
certain sHSP’s can inhibit amyloidogenesis in vitro (22, 27), while others have reported 
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that α-crystallins enhance amyloid formation and toxicity (28).  Specifically, Kudva et 
al. tested the ability of several sHSP’s from human and mouse to inhibit 
amyloidogenesis of A 1-42 (22).  They reported significant reduction in fibril formation 
as measured by thioflavin T fluorescence when substoichiometric amounts of both 
human sHSP27 and murine sHSP25 were added to the solution (22).  This is in stark 
contrast to Horwitz’s observation that equimolar amounts of the sHSP are necessary to 
inhibit aggregation of alcohol dehydrogenase or citrate synthase (11).  Also, Kudva 
reported that a mixture of αA-and αB-crystallin had no ability to inhibit 
amyloidogenesis under the conditions used (22).  In fact, Stege et al. reported that αB-
crystallin actually enhances the toxicity of the A (1-40) peptide (28).  No protection 
against aggregation of the amyloid-forming peptide was observed.  They reported that 
near-equimolar amounts of the crystallin increased neuronal cell death in culture.  The 
apparent light scattering due to aggregation also increased as did thioflavin T 
fluorescence (28). 
A Novel Small Heat Shock Protein from Babesia bovis 
A protein (HSP20) isolated by our lab from the bovine erythrocyte parasite 
Babesia bovis has shown very similar activities to that of the α-crystallin sHSP’s in 
initial in vitro studies.  Babesia, a hemoprotozoan parasite, causes damage to livestock 
and other animals including humans (29, 30). These parasites are single celled 
organisms, which can infect erythrocytes, as well as other blood cells such as 
lymphocytes and histiocytes (30).  Babesia species are the causative agents of "Texas 
red-water Fever" in cattle.  The parasite is often acquired from a bite by a tick 
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(Boophilus) vector.  The parasite enters the host erythrocyte and begins replication 
termed "binary schizogony" which eventually leads to death of the host cell (30). The 
merozoites released infect other cells and the process continues. The mortality rate in 
adult cattle is 90% if untreated. Symptoms include high fever, listlessness, and loss of 
appetite. The kidneys often excrete excess hemoglobin as a result of massive erythrocyte 
lysis (30). 
Though infection of cattle is usually controlled by elimination of the tick vector, 
the search for effective vaccines continues. Brown et al. (31) have examined the 
possibility of developing an effective subunit vaccine based on immunostimulatory 
proteins produced by B. bovis and bigemina. HSP20 was not only found to be a T-
lymphocyte stimulatory antigen, but also has homology to the α-crystallin family (31). 
This protein was isolated by members of our lab and is the subject of research in this 
dissertation. 
HSP20 has limited homology to members of the α-crystallin family, with the 
majority of the identical/conserved amino acids occurring in the region corresponding to 
the α-crystallin domain. It is known that this protein can exist as an oligomer (Ficht-
unpublished), but the form and structure of the protein under various solution conditions 
is not known. Also, the interactions between HSP20 and other proteins in solution have 
not been characterized.  Finally, the motifs responsible for the multimerization of the 
protein are not known. 
A recent collaboration with Dr. Theresa Good of the University of Maryland, 
Baltimore County has produced interesting results. It was shown experimentally that a 
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solution of HSP20 and Aβ(1-40) (BAP) formed fewer amyloid fibers than BAP alone. In a 
second experiment, the viability of neuronal cells exposed to a solution of BAP and 
HSP20 in vitro is greater than that of the same cell line exposed to BAP (27).  Therefore, 
HSP-20 has some very interesting qualities. Characterization of this protein will yield a 
better understanding of the activity of this class of molecular chaperones. Also, study of 
this protein could lead to a more complete understanding of amyloid formation and 
perhaps a therapeutic strategy for the amyloidoses. 
HSP20 is an intriguing protein with a great potential as a therapeutic against the 
amyloid diseases.  A basic study of the protein and its activities was undertaken to gain a 
better general understanding of the protein and evaluate this potential therapeutic value.  
Thus, this dissertation has three specific aims.  The first is a basic study of the protein 
HSP20 and its physical characteristics.  The second aim of this dissertation is to evaluate 
the activity of the protein as it relates to inhibition of unwanted aggregation of proteins 
and specifically amyloid fibril formation.  Finally, an examination of the domains 
controlling multimerization of HSP20 and what role they play in the activities of the 
protein is performed. 
HSP20 was shown to have homology to α-crystallins.  A more detailed analysis 
of the sequence and secondary structure of the protein revealed many similarities with 
known α-crystallins.  Sequence alignments with known members of this protein family 
were performed to determine residues and sequences that might be important to the α-
crystallin activity of the protein. 
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Because it has been reported on numerous occasions that α-crystallins have an 
inhibitory effect on the thermally-induced aggregation of certain proteins, a study of the 
aggregation inhibition activity of HSP20 was undertaken. Experiments were performed 
to confirm the activity of HSP20 with regards to inhibition of thermally-induced 
aggregation.  The next chapter discusses a protocol similar to that developed by Horwitz 
displaying the inhibition of aggregation of thermally denatured proteins by α-crystallin 
(11). 
Some work has been done by others indicating regions important for some α-
crystallins in forming oligomers (5, 32, 33).  These proteins were analyzed and the most 
likely corresponding regions in HSP20 were identified.  Deletions of these possible 
multimeric domains were made in an attempt to affect the multimeric state of the 
protein.  These various truncated forms of the protein were evaluated for aggregation 
inhibition. 
The ability of α-crystallins to inhibit amyloid fibril formation and toxicity is still 
a point of much debate (22, 28, 34-36).  In the following chapters, the amyloid inhibition 
activity of HSP20 was evaluated not only for the full-length form of HSP20, but for the 
truncation mutants that were found to be deficient in their ability to form multimers.  
Beyond gaining a better understanding of the α-crystallins and amyloidogenesis in 
general, it is hoped that this protein can be used to create a more effective therapeutic 
agent against the neurodegenerative diseases. 
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CHAPTER II 
MATERIALS AND METHODS 
HSP20 Gene Isolation 
The gene encoding the HSP20 protein was isolated using a cDNA library of the 
genome of Babesia bovis created by Dr. Barbara J. Ruef. The gene was ligated into the 
pMAL (NEB) expression vector by Dr. Ruef then transformed into TOP10 chemically 
competent E. coli cells.  A plasmid prep of this pMAL vector containing the DNA 
sequence for HSP20 was used as the PCR template of HSP20 described below. 
Construction of Expression vector Coding for HSP20  
HSP20 was produced as an N-terminal polyhistidine fusion protein (HisHSP20) 
in E. coli.  A plasmid prep of the pMAL vector containing the coding sequence for 
HSP20 was used as a template for a PCR to amplify the HSP20 gene for ligation into the 
pTrcHisTOPO vector (Invitrogen).  A typical PCR is illustrated below in Table 1.  
Primers (Table 2) were designed using MacVector (Accelrys) software and were ordered 
from IDT (standard desalting purification).  The forward primers were designed with an 
intervening Tobacco Etch Virus (TEV) protease site (37) between HSP20 and the 
polyhistidine tract.  This site could later be used to cleave the upstream purification tag 
incorporated into the recombinant protein by the expression vector. The PCR product 
was ligated into the pTrcHis TOPO protein expression vector (Invitrogen) and 
transformed into chemically competent TOP10 E. coli cells (Invitrogen) as directed by 
the manufacturer.  Briefly, 4 µl of the 25 µl PCR reaction was mixed with one micro 
liter of vector solution.  This mixture was allowed to incubate at room temperature for 5 
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minutes allowing the ligation of the insert into the vector to occur.  Two micro liters of 
this solution was then mixed with one tube (~100 µl) of chemically competent TOP10 E. 
coli cells on ice.  After a thirty minute incubation, the cells were heat shocked at 42°C 
for 30 seconds and immediately returned to ice.  This suspension of cells was then added 
to 250 µl of SOC media and incubated at 37°C for 20 minutes shaking on an orbital 
shaker.  Fifty to 100 µl of this culture was plated on LB agar containing 50 µg/ml 
carbenicillin.  Truncated forms of the protein were developed using a plasmid prep from 
the HisHSP20 clone as a template.  Primers were designed using the MacVector 
software as before and are listed below in Table 2.  PCR products were ligated into 
pTrcHisTOPO vector as described above and transformed into chemically competent 
TOP10 E. coli cells. 
 
 
Table 1:  Typical PCR setup for HSP20 coding regions 
Step Temperature 
(Time) 
Description 
1 Cycle 95°C (15 min) Initial melt and 
activation of 
AmpliTaq gold 
30 Cycles 95°C (30 sec) 
55°C (45 sec) 
72°C (60 sec) 
Duplex melt 
Anneal 
Elongation 
1 Cycle 72°C (10 min) Final Elongation 
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Recombinant HSP20 Preparation 
Transformed cells were plated on LB agar with 50 µg/ml carbenicillin.  Colonies 
were picked and streaked on new plates of LB agar and 50µg/ml carbenicillin.  Those 
streaks were picked and suspended in PCR mix.  A “colony screen” PCR was performed 
using a set of primers that contained one primer that annealed to vector and one primer 
that annealed to the insert.  This PCR mix results in a reaction that only produces the 
correct sized product if the insert is in the proper orientation within the vector.  Streaks 
corresponding to clones with the correctly sized and oriented insert were confirmed b 
sequence analysis and stored permanently as freezer stocks in 50% glycerol at -80°C. 
 
Table 2:  Primers used in generating coding regions of HSP20 
 
Primer Name Sequence Annealing 
Temperature 
(°C) 
Features 
Full-Length HSP20 
Forward 
Lab # F32901 
5’-GAA AAT CTT TAT 
TTT CAA GGT ATG TCG 
TGT ATT ATG AGG TGC-
3’ 
68.2 Contains 
TEV protease 
site coding 
region 
Full-Length HSP20 
Reverse 
Lab # F32901 
5’-CTA TTA GGC CTT 
GGC GTC AAT CTG 
AAC-3’ 
67.0 Contains stop 
codon  
    
C-del HSP20 
Reverse 
Lab # H40501 
5’-CTA TTA AGA GAA 
TTG AGA GCA CTC GAT 
CC-3’ 
64.2 Contains stop 
codon 
N-del HSP20 
Forward 
Lab # D52101 
5’-GAA AAT CTT TAT 
TTT CAA GGT ATT CCT 
CCT CCT AAG GAG TTG 
GAG AAC-3’ 
71.1 Contains 
TEV protease 
site coding 
region 
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HSP20 Protein Purification 
HisHSP20 was prepared by growing cells in LB broth at 37°C containing 
50µg/ml carbenicillin to OD600 of 0.5 followed by induction with 1mM IPTG for 5 
hours, and removal of media.  Cultures of cells induced with IPTG were collected by 
centrifugation at 8000xg for 20 minutes and 4°C.  The supernatant was removed and the  
cells were suspended in lysis buffer (6M Guanidinium-HCl, 0.5 M NaCl, 20 mM 
phosphate buffered at a pH of 7.8) followed by probe sonication (usually ten 30 second 
bursts using a Dynatech 150 Dismembrator).  Nickel resin (ProBond Resin from 
Invitrogen) was prepared according to manufacturer recommendations for a denaturing 
purification of the target protein. 
The cell lysate was clarified by centrifugation at 5000xg for 10 minutes and was 
incubated with the prepared nickel affinity resin for 1-2 hours to allow binding of 
HisHSP20.  The resin was then separated from the lysate by gravity or low speed 
centrifugation and washed several times each with two to three column volumes of two 
denaturing wash buffers at pH’s 7.8 and 6.0 respectively (Invitrogen ProBond Resin kit).  
The resin was finally washed in pH 6.0 wash buffer with 50mM imidazole to remove 
any trace contaminants still associated with the resin.  The proteins were eluted from the 
resin using 50 mM EDTA in a one step batch elution, followed by dialysis overnight into 
PBS pH 7.0, 20% glycerol and frozen at –20oC. Protein purity and molecular weight 
were confirmed by SDS PAGE.  A protein prep for all four forms of the protein is shown 
in Figure 4. 
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The final recombinant protein produced contained additional amino acids due to 
the expression vector purification tag and TEV protease site. The primary amino acid 
sequence of the full-length HisHSP20 protein is shown in Figure 5.  The coding 
sequence of HSP20 begins at amino acid 43 (Figure 5) of the recombinant HisHSP20.  
The truncation mutants have these same 42 amino acids preceding their coding 
sequences as well.  
Figure 4  SDS PAGE (12% polyacrylamide) of purified HisHSP20 forms.  BioRad 
Broad Range markers in left-most lane with molecular weights in kDa listed.  
Samples of full-length HisHSP20 (lane 1), N-terminal deletion NHisHSP20 (lane 2), 
C-terminal deletion CHisHSP20 (lane 3) and NC double deletion mutant 
NCHisHSP20 (lane 4) after nickel resin purification as described in Chapter II 
Materials and methods 
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Structural Analysis of HSP20 and Deletion Mutants 
Circular Dichroism Spectroscopy 
 CD experiments were carried out on an AVIV model 62 or 202 circular 
dichroism spectrophotometer.  Thermal stability scans were performed using 29µM 
protein samples.  The samples were placed in a 1mm cuvette and scanned from 250 to 
200 nm in 0.5 nm increments with a 5 second averaging time at each wavelength while  
 
 
1    ATGGGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAAATGGGTCGGGATCTGTACGACGATGACGAT
M  G  G S H  H  H  H  H  H G M A S M T G  G Q  Q M G R D L Y D  D  D  D 
91  AAGGATCCAACCCTTGAAAATCTTTATTTTCAAGGTATGTCGTGTATTATGAGGTGCAACAACGCCGACCAGGAGGTCATCATCGACGAG
K D P T L E N L Y F Q G M S C I  M R C N  N A D Q E V  I  I D  E 
181 CAGACTGGTCTCCCTATCAAGAGCCACGACTACAGTGAGAAGCCATCTGTCATCTACAAGCCTTCTACCACTGTCCCACAGAACACTCTT
Q T G L P I K S H D Y S E K P S V  I Y K P S  T  T V P Q N T L 
271 CTTGAGATTCCTCCTCCTAAGGAGTTGGAGAACCCGATTACTTTCAACCCAACTGTGGACACTTTCTTTGATGCTGACAACAACAAATTG
L E I P  P  P K E L E N P I T F N P T V D T F  F D A D N  N K L 
361 GTTTTGTTGATGGAACTTCCTGGTTTCAGCAGCACTGACATCAATGTTGAGTGTGGTTGGGGTGAATTGATCATCAGCGGCCCTCGTAAC
V  L  L  M E L P G F S  S  T D I N V E C G W G E L  I  I S G P R N 
451 AAGGATGAGCTTTACGAGAAATTCGGTAACAACTTGGACATTCACATTCGTGAGCGTAAGGTTGGTTACTTCTACAGGCGTTTCAAGCTT
K D  E L Y E K F G N  N L D I H I R E R K V G Y F Y R  R F K L 
541 CCCAACAACGCCATTGACAAGAGCATTAGCGTTGGCTACTCTAATGGTATTTTGGACATCAGGATCGAGTGCTCTCAATTCTCTGAGATG
P N  N A I D K S I S V G Y S N G I  L D I R I E C S Q F S E M 
631 CGCCGCGTTCAGATTGACGCCAAGGCCTAA
R  R V Q I D A K A * 
 
 
Figure 5  Primary sequence and amino acid translation of HisHSP20.  Illustrated using 
BioEdit software.  Black nucleotide sequence is from pTrcHisTOPO expression 
vector.  His purification tag(gray bar).  TEV Protease site encoded by primer (blue 
bar).  HSP20 amino acid sequence begins at residue 43. 
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being stirred by a magnetic stir bar.  The samples were equilibrated for 300 seconds at 
each temperature of 5,25,37,42 and 95 degrees before the spectrum was measured.  Data 
was imported into Microsoft Excel spreadsheets for visualization and analysis.  
Size Exclusion Chromatography 
The sizes of HisHSP20 oligomers as functions of concentration and solution 
conditions at room temperature were determined using size exclusion chromatography 
on a Pharmacia FPLC system.  Protein samples of 100 µl at various concentrations were 
loaded onto a Superose 6 HR 10/300 column (Pharmacia) and eluted using PBS (10 mM 
phosphate, 120 mM NaCl, pH 7.4).  Eluted proteins were detected using UV absorbance 
at either 280 nm or 254 nm.  Oligomer sizes were estimated based on the elution 
volumes of a set of calibration proteins run on the same column under similar conditions.  
The standard curve generated with the set of known molecular weight standards is 
shown in the Figure 6.  The void volume was measured using Blue Dextran 2000 and 
found to be 7.81 ml.  The bed volume of the column was determined by pir2h to be 
24.186 ml.  These values were used in calculating the Kav for a particular elution volume 
using the following formula (equation 1). 
Kav = (Ve-Vo)/ (Vt-Vo)    (1) 
 
In equation 1, Ve is elution volume, Vt is bed volume and Vo is the void volume.  The 
value of Kav was determined based on each elution volume observed and the standard 
curve in Figure 6 was used to determine an apparent molecular weight. 
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Figure 6  Plot of Kav vs. log of molecular weight of standard proteins eluted from 
Superose 6 10/300 column (Pharmacia).  Elution volumes for each standard were 
measured and a value of Kav for each standard was determined using equation 1.  The 
plot above was generated in Microsoft Excel.  The equation for the line of best fit 
applied to the data points above was used as a standard curve in determining the 
apparent molecular weight of experimental samples from their calculated Kav. 
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  A second column (Superdex 200 HR-Pharmacia) was used in later analyses of 
the truncated forms of the protein.  The resolving range of this column is approximately 
10 kDa to 600 kDa.  The void volume for this column as determined by Blue Dextran 
elution was 9.795 ml and a bed volume of 23.94 ml.  As before, a set of standards were 
eluted from this column under experimental conditions.  The elution volumes were used 
in calculation of the Kav for each standard using equation 1.  These values were plotted 
versus the log of the standards’ molecular weights and a standard curve was generated 
(Figure 7).  This column was used to separate the proteins under native conditions using 
PBS and 100 µl samples as above.  In addition, this column was used to separate cross-
linked forms of the protein under denaturing conditions.  In this case, 6M guanidine 
hydrochloride, 500 mM NaCl, 20 mM phosphate pH 7.8 was used as the mobile phase.   
Radiolabelling of Proteins 
E. coli cells containing the HSP20 expression vector were grown to an OD600 of 
0.5 in LB broth at 37°C while shaking.  The cells were then pelleted by centrifugation at 
8000xg and 4°C for 20 minutes followed by removal of the growth media.  The cell 
pellets were washed with 1X M9 minimal salts media (Difco).  The cells were pelleted 
by centrifugation again and the media was removed. The cells were suspended in 
minimal growth media supplemented with thiamine (0.002% w/v), glucose (0.01% w/v) 
and all amino acids (0.01% w/v) except methionine.  Radiolabeled 35S-Methionine 
(Amerscham Pharmacia) was added (2.5 mCi) to the media.  The cells were then 
induced with 1mM IPTG for up to 5 hours at 37°C with shaking as described before.  
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Cells were harvested by centrifugation, followed by lysis and protein purification as 
described above. 
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Figure 7  Plot of Kav vs. log of molecular weight of standard proteins eluted from S200 
column.  Elution volumes for each standard were measured and a value of Kav for each 
standard was determined using equation 2.  The plot above was generated in Microsoft 
Excel.  The equation for the line of best fit applied to the data points above was used as a 
standard curve in determining the apparent molecular weight of experimental samples 
from their calculated Kav. 
 
 
Sedimentation Velocity Ultra Centrifugation with Radiolabeled Proteins 
Purified, radiolabeled protein samples were diluted to equal concentrations in 
PBS.  Typically, 100 µl were placed on a 5 to 30% glycerol gradient.  The gradient was 
centrifuged in a Beckman LS-80M ultra centrifuge, SW-41 rotor at 35000 rpm 
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(150,000xg) for 48 hours at 4°C.  The sample tubes were punctured and drained from the 
bottom into fractions.  Typically, 12-ml volumes of gradients were created and these 
were fractionated into 0.5-ml fractions.  Fractions were diluted to 5 mls using Ecoscint 
XR scintillation fluid and analyzed on a Beckman scintillation counter.  The 35S window 
was read for each sample for 2 minutes.  Average values were recorded and plotted in 
Excel software.  Plots were generated as percentage of total counts observed for each 
fraction versus the fraction number. 
Cross-linking of Multimeric Forms Using Glutaraldehyde 
The multimeric state of HSP20 forms were analyzed using a chemical cross-
linker followed by separation via poly acrylamide gel electrophoresis or size exclusion 
chromatography.  Protein samples were diluted in HGNED (1mM DTT, 100 mM NaCl, 
0.2M EDTA, 0.05% v/v NP-40, 10% v/v glycerol, 25 mM HEPES, pH 8.0) buffer to the 
desired concentration.  The samples are allowed to equilibrate before adding 
glutaraldehyde to a final concentration of 0.01% v/v.  The reaction is quenched by the 
addition of a 1M Tris 1M Glycine solution at time points between 5 and 20 minutes. 
PAGE Analysis 
Native and Denaturing (SDS) PAGE analysis were performed on samples using 
the BioRad Mini Protean II system.  Samples were combined with equal volumes of 2X 
SDS loading dye containing SDS, beta mercaptoethanol and glycerol.  Samples were 
boiled for 5 minutes prior to running.  Various gels were used including hand-poured 
12% native and SDS gels as well as 4-20% gradient gels purchased from LifeGels.  Gels 
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were stained in standard Coomassie staining solution for approximately one hour and 
destained over night. 
Staining of Gels with SYPRO Ruby Stain 
As an alternative to standard Coomassie staining of protein gels, SYPRO Ruby 
stain (Molecular Probes-Invitrogen detection technologies, cat # S12001) was employed 
using the “rapid protocol” included with the purchase of the staining solution.  After the 
gel was subjected to electrophoresis, it was placed in 100 ml of fixing solution (50% 
methanol, 7% acetic acid (v/v)) for 15 minutes at room temperature on an orbital shaker.  
This procedure was repeated after the fixing solution was removed and replaced with 
fresh solution.  The gel was stained with 60 ml of SYPRO Ruby gel stain by heating in a 
microwave at maximum power for 30 seconds followed by agitation for 30 seconds.  
The solution was heated an additional 30 seconds to a temperature of approximately 
80°C and agitated at room temperature for 5 minutes.  The sample was heated for 30 
seconds in a microwave again and allowed to incubate at room temperature on an orbital 
shaker for an additional 23 minutes. The gel was washed in 100 ml of wash solution 
(10% methanol, 7% acetic acid (v/v)) for 30 minutes.  Finally, the gel was washed 
several times with distilled water before imaging with a digital camera on a 
transilumination base emitting at 280 nm.  
Western Blotting 
Western blotting was used to confirm the presence of HSP20 forms on PAGE 
gels.  After running gels as described above, the gel was placed in ice-cold transfer 
buffer (3g tris-HCL, 14.6g glycine and 20% (v/v) methanol in double-distilled H2O).and 
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inserted into the transfer apparatus (BioRad MINI-Protean II Transfer System) according 
to manufacturer’s recommendations.  Samples were transferred to nitrocellulose 
membrane (PROTRAN transfer and immobilization membrane-Schleicher &Schuell) at 
100V for 1 hour in a cold circulating bath.  Membranes were blocked for 1hr. in 20 ml of 
3% gelatin TBS(10 mM tris, 500mM NaCl, pH 8.0) or for 3 hours in 10%(v/v) milk in 
TBS+0.05% Tween-20(TBST) shaking on an orbital shaker at room temperature.  The 
membrane was washed three times with 10 ml of TBST for 10 minutes each time.  
Primary antiserum (polyclonal antiserum “32.12 from rabbit Sinclair 1:20”-raised in 
rabbits against HSP20 by Barbara Ruef 1999) was diluted 1:50 (total dilution 1:1000) in 
1% gelatin-TBS (or 10% milk TBST). The membrane was incubated with 5 ml of 
primary antibody solution for 2 hours shaking.  To visualize trace amounts of proteins in 
multimeric forms, the membrane was incubated with the primary antiserum in 10% milk 
and TBST over night at 4°C rotating on a rolling drum.  The membrane was washed two 
times with 10 ml of TBST for 10 minutes followed by two 10 minute washes in 10 ml of 
TBS.  The secondary antibody (goat anti-rabbit IgG H&L phosphate labeled (cat #075-
1506 KPL)) was diluted 1:5000 into 10 ml of 1% gelatin TBS or 5%v/v milk in TBS.  
The membrane was reacted with this solution for 1 hour, shaking.  The membrane was 
washed twice for 5 minutes in 10 ml of TBST followed by two 5-minute washes in 10 
ml of TBS.  The development solution consisted of one tablet of BCIP/N (Sigma) in 10 
ml of double distilled H2O.  The solution was reacted with membrane until bands were 
easily discernable.  Washing the membrane in 100mM EDTA in water quenched the 
reaction. 
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Analysis of Activities of HSP20 and Deletion Mutants 
Aβ Peptide Preparation.   
A (1-40) was purchased from BioSource International (cat# 03-138) as a 
lyophilized trifluoroacetic acid salt.  Stock solutions of 10 mg/ml Aβ(1-40) peptides 
were made up in 0.1% (v/v) trifluoroacetic acid (TFA) in water.  The peptide stock 
solutions were immediately diluted to concentrations of 0.5 mg/ml by addition of sterile 
phosphate buffered saline (PBS; 0.01 M phosphate, 0.12 M NaCl, pH 7.4). The peptides 
were diluted to final concentration of 50 µM by addition of PBS for Congo red and 
thioflavin T analysis.  These peptide solutions were combined with various amounts of 
different HisHSP20 forms and rotated on an orbital platform shaker in 1.5-ml Eppendorf 
tubes horizontally at 25°C for 24-48 hours to ensure aggregation. 
Congo red Binding   
Congo red studies were performed to assess the presence of amyloid fibrils in Aβ 
solutions.  Congo red dye (Sigma) was dissolved in PBS (10 mM phosphate, 120 mM 
NaCl) to a final concentration of 120 mM.  Congo red solution was added to the peptide 
solutions at the ratio of 1:9.  The peptide solution and control solution were allowed to 
interact with Congo red for 30-40 minutes in a dark enclosure prior to absorbance 
measurement with a Response II UV-Vis spectrophotometer (Gilford) at 25°C.  The 
fibril formation of the samples was estimated from the absorbance using equation 2 (38). 
 
[AβFib ]  =   (541 At / 4780) -  (403 At / 6830) -  (403 ACR  / 8620)    (2) 
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where [AFib] is the concentration of A fibril, 541At , 403At and 403ACR are the 
absorbances of the sample and Congo red at the wavelength of 541nm and 403nm, 
respectively (38). From these data, relative fibril concentrations were calculated as the 
ratio of sample fibril concentration to pure A fibril concentration.  
Thiflavin-T Binding 
Amyloid fibril formation was also evaluated by thioflavin-T fluorescence.  198 
µl of amyloid samples in PBS were combined with 2 µl of 500µM thioflavin-T in 50mM 
glycine-NaOH buffer, pH 8.5.  Samples were loaded on 96-wel fluorescence plates and 
evaluated using a Molecular Dynamix Gemini II fluorescence plate reader.  Excitation 
wavelength of 444 nm and emission wavelength of 485 nm were used.  
ADH Turbidity Assay 
Light scattering of alcohol dehydrogenase (ADH) and HSP20 was performed as 
previously described (11).  Briefly, the aggregation of ADH and HSP20 in solution was 
measured by the apparent absorption due to scattering at 360 nm in a Gilford Response 
II spectrophotometer.  HSP20 concentrations were varied to obtain different molar ratios 
of Hsp20 to ADH.  Initial experiments were performed as a time course at 58oC using 
the Thermoset attachment (Gilford) with readings being taken once every minute for up 
to 90 minutes.  Later experiments were performed after a 20 minute incubation at 58°C 
followed by a single absorbance reading at 360 nm. 
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CHAPTER III 
CHARACTERIZATION OF HSP20 
Introduction 
The protein HSP20 isolated from the bovine erythrocyte parasite Babesia bovis 
was initially characterized as a member of the α-crystallin family of small heat shock 
proteins.  This was determined using the BLAST database comparison software 
available to the public via the internet.  Though bioinformatics indicated the structural 
motifs of the protein to be consistent with other α-crystallins, a more extensive study 
was performed to confirm this classification.  The form of the protein purified and 
studied below also incorporates the 6-histidine purification tag.  This form has an 
additional 42 amino acids on the N-terminus of the wild type protein and is designated 
HisHSP20.   
The following results section contains analyses of the full-length form of 
HisHSP20.  First, structural studies of the protein were performed using secondary 
structure prediction algorithms and circular dichroism.  The stability and overall 
secondary structure of HisHSP20 was determined.  The multimerization of HisHSP20 
was explored using various techniques such as gel electrophoresis, and size exclusion 
chromatography.  The effects of solution conditions and concentration on the multimeric 
population of HisHSP20 were examined.  Finally, an evaluation of the chaperone 
activity of HisHSP20 was performed.  Using protocols developed previously (11, 27), 
the thermally induced aggregation of ADH and amyloid formation of Aβ peptide were 
evaluated in the presence of various amounts of HisHSP20. 
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Results 
Structural Studies of HisHSP20 
Table 3 contains basic chemical information for HisHSP20 such as calculated pI 
and molecular weight (39, 40).  
 
 
Table 3:  Basic chemical parameters of HisHSP20 
Number of Amino acids Molecular 
Weight 
Theoritical pI Extinction Coefficienta 
219 (174 code for HSP20) 24,897 Da 5.13 17670 
a
 Extinction coefficient is in units of  M-1 cm-1, at 280 nm assuming all Cys residues 
appear as half cystines 
 
 
The primary sequence of HSP20 is reported in the following sequence alignment 
(Figure 8).  Also contained in this alignment are other known members of the α-
crystallin family (M jannaschii HSP 16.5 (15) and wheat HSP16.9 (6)).  The putative α-
crystallin domains as well as the N and C-terminal domains are indicated in Figure 8 as 
as reported by Sun et al (1).  The α-crystallin domain of HisHSP20 was identified using 
Motif Scan software (41) to be from amino acid 74 to 174.  Though there is limited 
sequence homology between these three proteins, there is significant secondary 
structural homology as determined by PSIPRED software (42, 43).   The secondary 
structural elements are indicated as blue bars (alpha helices) and green arrows (beta 
sheets). 
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N-terminal domain
α-crystallin domain
C-terminal domain
Wheat16.9 1 ------------MSIVRRSNVFDPFADLWADPFDT-FRSIVPAISGGGSETAA------- 40
M.jan16.5 1 --------------MFGRDPFDSLFERMFKEFFATPMTGTTMIQSSTGIQISG------- 39
HSP20_full_length 1 MSCIMRCNNADQEVIIDEQTGLPIKSHDYSEKPSVIYKPSTTVPQNTLLEIPPPKELENP 60
Wheat16.9 40 ---FANARMDWKETPEAHVFKADLPGVKKEEVKVEVEDGNVLVVSGERTKEKEDKNDKWH 97
M.jan16.5 39 ---KGFMPISIIEGDQHIKVIAWLPGVNKEDIILNAV-GDTLEIRAKRSPLMITESERII 95
HSP20_full_length 61 ITFNPTVDTFFDADNNKLVLLMELPGFSSTDINVECGWGELIISGPRNKDELYEKFGNNL 120
Wheat16.9 98 RVERSSGK---FVRRFRLLEDAKVEEVKAGLENGVLTVTVPKAEVKKPEVKAIQISG 151
M.jan16.5 96 YSEIPEEEE--IYRTIKLPATVKEENASAKFENGVLSVILPKAES--SIKKGINIE- 147
HSP20_full_length 121 DIHIRERKVGYFYRRFKLPNNAIDKSISVGYSNGILDIRIECSQFSEMRRVQIDAKA 177
Figure 8  Sequence alignment of full length HSP20 with M. jannaschii 16.5 and wheat HSP16.9.  ClustalW 1.82 
was used for alignment.  Identical amino acids are labeled black, conserved residues are labeled grey.  Secondary 
structure elements as predicted by PSIPRED software:  Alpha helices (blue bars) Beta sheets (green arrows).  N 
and C terminal and α-crystallin domains were determined by Sun et al.(1)   
38 
 
Though the amino acid sequence homology is fairly low, the majority of the 
identical/conserved residues occur in the region classified as an α-crystallin domain.  In 
fact, the amino acid homology between M. jannaschii 16.5 and wheat 16.9 is also low.  
The group of α-crystallins varies markedly in their primary amino acid sequence while 
the secondary structural elements are very similar.  The secondary structure prediction 
shows a similar beta-sheet region in all the proteins corresponding to -crystallin domain 
areas.  There are specific amino acid residues that have previously been determined to be 
very important to the function of M. jannaschii HSP16.5 and wheat 16.9.  For example, 
in a previous chapter, it was noted that Arg107 in  M. jannaschii 16.5 and Arg 108 in 
wheat 16.9 are highly conserved (6).  This residue is conserved in HSP20 as well at 
residue 134 (Figure 8).  This and other regions are discussed in more detail at the 
conclusion of this chapter.  
Secondary Structure Measurements of HisHSP20 
Cicular dichroism is used to determine overall secondary structure of proteins in 
solution.  Beams of left- and right-circularly polarized light are absorbed differently by 
protein molecules.  Different secondary structure configurations such as beta sheet and 
alpha helices have distinct CD spectra (44).  Figure 9 illustrates the different spectra 
observed for some common secondary forms of poly-lysine.   
Alpha helical secondary structure is characterized by a spectrum with two 
minima at 208 and 222 nm while beta sheet structure results in a spectrum with a single 
minimum at 217 nm. Random coil structure has one minimum at about 195 nm (Figure 
9).  The spectra depicted in Figure 9 are used as standards of spectra obtained for these 
secondary structural elements (44).  
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Figure 9  Model circular dichroism spectra of poly-lysine in three secondary structures.  
Alpha helix (blue) is shown with two minima at 208 and 222 nm.  β-sheet (red) is shown 
with minimum at 217 nm and random coil (green) with a minimum at 195 nm (44). 
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A number of major parameters of protein activity and stability were investigated 
for HSP20 to probe the variety of functions this molecule may perform. In light of the 
requirements for thermal insulation activities of this protein, the thermal stability of 
HSP20 was evaluated.  Heat shock proteins are inherently stable over a broad 
temperature range, thus they remain active in the most adverse of conditions.  To explore 
the thermal stability of HisHSP20, the secondary structure of the protein from 5°C to 
95°C is monitored using circular dichroism.  Figure 10 displays the CD spectra of the 
protein at several temperatures.  The single minimum at ~217 nm in Figure 10 indicates 
a predominance of -sheet secondary structure.  Also, the intensity of the signal is 
relatively unchanged over the temperatures evaluated.  From the standpoint of secondary 
structure, the protein is very stable over the temperature range of 5 to 95°C.   
Studies of the Multimeric Forms of HisHSP20 
The ability of the α-crystallins to form multimers in solution has been 
documented numerous times.  The multimeric population can be over a wide range of 
polydisperse species or monodisperse in nature (4, 17, 45-47).  HSP20 forms multimers 
in solution as well.  This was first illustrated by gel electrophoresis and is shown in 
Figure 11.  Polyclonal rabbit antiserum was raised against a truncated form of HSP20 
prior to these studies.  This antiserum was used to probe western blots (see Chapter II) of 
the protein under various conditions in an attempt to visualize the multimeric state of the 
protein. Using native PAGE analysis, multimeric forms of the protein were observed. 
41 
 
 
 
 
Figure 10  Far UV CD Spectra of 29 µM full-length HisHSP20 in 10 mM 
phosphate, 120 mM NaCl from 5 to 95°C.  Samples were equilibrated at each 
temperature for 5 minutes prior to reading.  Pathlength was 1 cm.   
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In Figure 11, two native gels loaded with 80µM samples of HisHSP20, one 
stained with Coomassie, the other analyzed by western blot are shown.  The majority of 
the protein fails to migrate into the gel with the Coomassie staining only showing protein 
at the very top of the gel.  But clearly, other bands are visible using the polyclonal 
antiserum.  These bands correspond to multimeric forms of the protein.  Under these 
conditions, the protein forms a polydisperse population of multimeric species in solution.  
The vast majority of the protein however is still in very large complexes which do not 
migrate into the gel enough for proper resolution. 
Another strategy used to visualize multimers of the protein involves the use of 
covalent cross linking.  HisHSP20 was allowed to come to equilibrium under a set of 
solution conditions and the chemical cross-linker glutaraldehyde was added to 
covalently link any multimeric species.  The cross-linker was quenched at specific time 
points in order to ‘capture’ the multimers at various stages. The samples were analyzed 
by SDS gel or SEC.  A time course of cross linking of HisHSP20 is shown in Figure 12.  
In Figure 12A, samples of HisHSP20 cross-linked for 0, 10 or 20 minutes were 
separated on a 4-20% gradient SDS gel and stained with SYPRO Ruby fluorescent stain.  
At time 0, the majority of the protein is a monomer as evidenced by the band migrating 
with the 25kDa standard in the left hand lane.  In as little as ten minutes, the majority of 
the monomer (25 kDa) has been cross linked into some large species.  The resolution of 
the gel  is from 10 kDa to 250 kDa.  Thus, in very little time, large cross-linked 
aggregates of the protein are seen. 
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Figure 11  Native PAGE of HisHSP20 stained with Coomassie or detected via western 
blot.  Multimers of purified HisHSP20 at 80 µM concentrations were separated on a 
12% native gel and stained with Coomassie (middle lane) or were transferred to 
nitrocellulose membrane and probed with polyclonal antiserum raised against 
HSP20(right lane).  BioRad Kaleidoscope marker in left lane is shown with 
corresponding molecular weights in kDa.  
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Figure 12  SDS PAGE (4-20% gradient) separations of cross-linked samples of 
HisHSP20.  A)  Equimolar samples were equilibrated at room temperature prior to 
glutaraldehyde cross-linking.  Cross-linker was quenched at 0, 10 and 20 minutes and 
samples of each time point (indicated by labels below lanes) were separated on gel.  
Broad Range Precision Molecular weight Standards (BioRad) is shown in left-hand lane 
with molecular weights in kDa.  Arrow indicates dimeric form of the protein.  Stained 
with SYPRO Ruby stain (BioRad) and visualized by fluorescence from exposure to 280 
nm light.  B) Western blot of cross-linked samples of HisHSP20.  Equimolar samples 
were equilibrated at room temperature prior to glutaraldehyde cross-linking.  Cross-
linker was quenched at 0,10 and 20 minutes and samples of each time point (indicated 
by labels below lanes)were separated on a 4-20% gradient SDS PAGE gel.  
Kaleidoscpoe marker (BioRad) is shown in left-hand lane with molecular weights in 
kDa.  Samples were blotted to nitrocellulose membrane and probed using antiserum 
raised against HSP20 as described in Chapter II. 
 
 
In Figure 12B, a western blot of HisHSP20 cross-linked under the same 
conditions and separted on the same type of gel is shown.  Clearly, several multimeric 
forms of the protein are visible.  It is interesting to note that the sample with no cross 
linker added (0 time point) still exhibits the multimeric forms of the protien to a great 
degree despite the presence of SDS in the running buffer.  From these results, we 
concluded that HisHSP20 forms a polydisperse population of multimers in solution. 
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Figure 13  Elution profile of full-length 100 µM HisHSP20 from a Superose 6 10/300 
column.  HisHSP20 elutes over a broad range corresponding to molecular weight s from 
45 kDa(dimer) to 261 kDa (decamer) relative to size exclusion standards indicated at top 
of graph:  thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa) and lysozyme 
(14.4 kDa).  Void volume is indicated for column at 7.81 ml.  HisHSP20 at 100 µM in 
10 mM phosphate, 120 mM NaCl pH 7.4. 
 
 
 
The Effect of Concentration on the Multimeric Distribution of HisHSP20 
Le Chatellier theorized that a system at equilibrium will react to a change in 
conditions in order to establish a new equilibrium under those conditions.  Thus, if a 
multimeric form of HisHSP20 dominates a solution at one concentration, lowering the 
concentration should allow for the establishment of a new equilibrium with fewer 
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multimers and a subsequent increase in smaller multimer and monomer forms.  We 
employed size exclusion chromatography (SEC), to elucidate the multimeric state of 
HisHSP20.  By changing the solution conditions, the multimeric population was altered.  
A representative chromatogram of HisHSP20 at 100 µM is illustrated in Figure 
13.  The very low peak height indicates that very little protein eluted from the column.  
The remainder of the protein was recovered by reversing the flow of the mobile phase.  
This indicated that the protein never entered the separation media of the column.  
Extremely large complexes (or aggregates) were present as the resolving range of this 
particular column (Superose 6 HR 10/30) is from 5 MDa to 5 kDa.  Using a standard 
curve (see Chapter II Materials and Methods), the elution volumes were converted to 
apparent molecular weights.  The volumes highlighted correspond to molecular weights 
of 261, 142 and 45 kDa.  These sizes are equivalent to the molecular weight of a 
decamer, hexamer and dimer respectively. 
The following figure is of a chromatogram generated on the same column under 
the same buffer conditions, but a concentration of 0.1 µM HisHSP20.  In the 
chromatogram in Figure 14, the only peak seen is at an elution volume of 20.184 ml.  
This corresponds to a molecular weight of approximately 44 kDa (a dimer).   
The Effect of High Salt on the Multimeric Distribution of HisHSP20 
The effect of increased ionic strength on multimeric assembly was evaluated by 
increasing the concentration of sodium chloride (0.5 M) in the running buffer of the SEC 
separation.  Higher salt shields electrostatic interactions to a greater degree which 
resulted in a change in the multimeric population by weakening the electrostatic  
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Figure 14  Elution profile of full-length 0.10 µM HisHSP20 from a Superose 6 10/300 
column.  HisHSP20 at 0.1 µM elutes as a single peak corresponding to molecular weight 
of 45 kDa (dimer) relative to size exclusion standards indicated at top of graph:  
thyroglobulin(669 kDa), ferritin (440 kDa), aldolase (158 kDa) and lysozyme (14.4 
kDa).  Void volume is indicated for column at 9.81 ml.  HisHSP20 at 100 µM in 10 mM 
phosphate, 120 mM NaCl pH 7.4 
 
 
contribution to multimerization.  Figure 15 depicts an elution profile of HisHSP20 in 
10mM phosphate, 50mM NaCl.  The dimeric form predominates (peak D in Figure 15) 
with other multimeric forms ranging from hexadecyl to monomeric eluting as well.  The 
area under the curve of this elution spectrum indicated that over 90% of the protein did 
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Figure 15  Elution profile of full-length HisHSP20 from a Superose 6 10/300 column in 
the presence of 500 mM NaCl.  HisHSP20 at 29 µM elutes as a series of peaks 
corresponding to molecular weights A)399-264 kDa(hexadecamer to decamer), B)153 
kDa (hexamer), C)109 kDa (tetramer) and D)56 kDa (dimer) relative to size exclusion 
standards indicated at top of graph:  thyroglobulin (669 kDa), ferritin (440 kDa), 
aldolase (158 kDa) and lysozyme (14.4 kDa).  Void volume is indicated for column at 
9.81 ml.  HisHSP20 at 100 µM in 10 mM phosphate, 500 mM NaCl pH 7.4 
not elute from the column.  This dynamic polydisperse population of multimers is 
influenced significantly by solution conditions.   
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Another separation technique employed was sedimentation velocity via 
analytical ultracentrifugation.  Glycerol gradientts (5-30%) were used to provide 
resistance to samples of radiolabeled HisHSP20 as they were centrifuged at 150,000xg 
for 48 hours at 4°C as described in Chapter II.  The various multimeric forms migrate 
along the gradient at different rates determined by their size and shape.  The result from 
one such experiment is shown in Figure 16.  
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Figure 16  Elution profile of 35S radiolabeled full-length HisHSP20 from a 5-30% 
glycerol gradient.  Sample was centrifuged at 150,000 xg for 48 hrs. at 4°C.   Fractions 
were collected from bottom of gradient and radioactivity was read using scintillation 
counting.  Percentage of total counts for each sample is plotted vs. fraction number.  
Molecular weight standards of ferritin (fraction 4-440 kDa) and bovine serum albumin 
(fraction 14-66 kDa) were detected by absorbance of each fraction at 280 nm in a 
separate gradient ran under the same conditions. 
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In this figure, a broad symetrical peak centered around fraction 15 of the 12-ml 
gradient is detected as well as a minor peak at fraction 23 near the top of the gradient.  
The major peak  indicates several multimeric species in the population.  Two standards 
(ferritin MW 440 kDa , 17.6 S and Bovine Serum Albumin, 66 kDa and 4.3 S) are 
shown eluting at fractions 4 and 14 respectively for reference.  The leading edge of the 
large peak at fraction 11 corresponds to 8.3 S and a molecular weight of 178 kDa ( 7.4 
times the molecular weight of monomeric HisHSP20).  The broad peak elutes over 13 
fractions indicating a broad dispersion of multimers. 
The hypothesis that a broad population range of multimeric species were present 
in solution under the condtions tested, is supproted by all these experiments. (SEC, 
PAGE and sedimention velocity).  Dilution of the protein results in an equilibrium shift 
to a population of  smaller oligomeric species which can also be observed under high salt 
conditions again indicating that the protein forms extremely large and dynamic 
complexes whose distribution is affected greatly by solution conditions. 
Activities of HisHSP20 
As stated in Chapter I, one of the activities commonly observed of an α-crystallin 
is the inhibition of thermally-induced aggregation.  Thus, one of the first experiments 
performed on HSP20 was based on Horwitz’s protocol (11) in which the aggretaion of 
alcohol dehydrogenas (ADH) at high temperature is arrested by the presence of a bovine 
α-crystallin.  Similar protocols have been used to evaluate α-crystallins using ADH and 
other proteins such as citrate synthase as substrates for thermal denaturation/aggregation 
(48-63).  As an evaluation of chaperone activity, the aggregation of ADH in the presence 
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of HisHSP20 at elevated temperature was monitored as described in Chapter II using 
apparent light scattering of the sample at 360 nm. 
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A representative result of this apparent light scattering of ADH in the presence 
and absence of HSP20 is illustrated in Figure 17.  The absorbance at 360 nm of a 
solution of ADH at 58°C (red circles of Figure 17) increased dramatically over time.  
When HisHSP20 is combined with ADH in solution (blue triangles of Figure 17), a 
Figure 17  Aggregation of ADH in presence and absence of HisHSP20 at elevated 
temperature.  Measurements of apparent light scattering (turbidity) of solutions at 
58°C vs. time.  ADH alone (red circles) exhibits a dramatic increase in absorbance at 
360 nm due to aggregation within 20 minutes.  ADH+HisHSP20 (blue triangles) 
shows significantly less turbidity.  ADH at 3.25 µM, HisHSP20 at 5µM. 
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dramatic reduction in absorbance at 360 nm was observed indicating less aggregation of 
the substrate ADH.  In this experiment, a molar ratio of HSP20 to ADH of 1.54:1 was 
used. 
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In order to evaluate the effect of concentration of HisHSP20 on its inhibition of 
Figure 18  Apparent light scattering of ADH in the presence of different amounts of 
HisHSP20.  The concentration of ADH is kept at 3.25 E-6 M. Molar ratios of 
HisHSP20 to ADH are indicated on x-axis.  Samples were incubated for 20 minutes 
at 58°C prior to measuring absorbance at 360 nm.  Absorbance of each sample was 
compared to absorbance of a sample of ADH alone.  The percentage of absorbance 
compared to that of the ADH standard is plotted on the y-axis for each molar ratio.  
Error bars are 1 SEM.  n=3 
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thermally induced aggregation, a series of molar concentrations of HSP20 were 
combined with ADH and the same light scattering assay was performed.  Figure 18 
illustrates the thermal insulation activity of HSP20 for ADH over varying molar ratios.  
In this experiment, one absorbance reading at 360 nm was taken of each solution after 
exposure to elevated temperature for 20 minutes.  
The ratios of 2:1, and 1:1 (HisHSP20: ADH) show the largest reduction in light 
scattering at greater than 90% each (Figure 18).  As the molar ratio is decreased, the 
protection against light scattering (apparent aggregation) is reduced.  At a 1:5 molar 
ratio, little protection is seen.  This is comparable to Horwitz’s work with bovine αA-
crystallin (11).  It was also noted in Figure 18 that as the concentration of HisHSP20 was 
increased, the apparent light scattering increases (molar ratio of 5:1 in Figure 18).  This 
increase in concentration is accompanied by a change in the multimeric distribution of 
HisHSP20 according to the earlier SEC results.  This is indicative of an equilibrium shift 
toward a less active form of HisHSP20.  In any case, it is clear that HisHSP20 is an 
inhibitor of aggregation under these experimental conditions. 
As discussed earlier, there have been conflicting results concerning the activity 
of -crystallins and inhibition of amyloid fibril formation.  A series of experiments are 
described below detailing the activity of HisHSP20 with respect to amyloidogenesis.  
Full-length HisHSP20 was placed in solution with amyloidogenic A
 (1-40) peptide (BAP) 
and allowed to incubate at room temperature in an effort to observe any inhibition of 
fibril formation by BAP.  The samples were analyzed after 24 hours of incubation using 
Congo red dye binding and thioflavin T fluorescence.  A representative result of 
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HisHSP20 in solution with BAP at several molar ratios is shown in Figure 19.  
Interestingly, amyloid inhibition is seen at certain molar ratios and not at others.  This 
data correlates with data collected by Dr. Theresa Good’s lab (formerly of TAMU 
Chemical Engineering Dept. and currently at University of Baltimore at Maryland 
Department of Chemical Engineering) which showed an even lower range of effective 
molar ratios (1:1000 to 1:1 million of HisHSP20 to BAP) (27).  
It is very interesting to note that at a molar ratio of 1:1, the protein seems least 
effective at inhibiting amyloid formation and even seems to promote formation.  This is 
a quite different result from the thermally-induced aggregation of ADH shown earlier 
where equimolar amounts of HisHSP20 are needed to inhibit aggregation of ADH.  
However, the same trend of a specific substoichiometric range of concentrations 
resulting in inhibition of amyloidogenesis is observed in both cases. 
Summary and Discussion 
Here it has been established that the novel protein HSP20 exhibits activities 
typical of those observed in -crystallins.  The protein has significant structural 
homology to other known members of the small Heat Shock Proteins (M jannaschii 16.5 
and wheat 16.9).  The protein is stable over a wide temperature range and it seems to 
form very large and dynamic ordered complexes as other -crystallins have been shown 
to do.  The protein has been shown to inhibit the thermally induced aggregation of 
alcohol dehydrogenase as well.  This is a common trait shared with many (if not all) - 
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Figure 19  Inhibition of amyloid fibril formation by full-length HisHSP20.  Samples of 
Aβ(1-40) were incubated at room temperature for 24 hours alone or in the presence of 
different amounts of HisHSP20.   Concentration of Aβ (1-40) is kept at 50 µM.  Molar 
ratios of HisHSP20 to Aβ (1-40) are indicated on x axes.  Samples were analyzed by 
Congo red binding (top) or thioflavin-T fluorescence (bottom) as described in Chapter II.  
Congo red binding in top panel was used to calculate amount of fibrils formed using 
equation 1. Amount of fibrils formed in each sample was compared to amount of fibrils 
in a sample of Aβ (1-40) alone.  The percentage of fibrils compared to that of the Aβ (1-40) 
standard is plotted on the y-axis for each molar ratio.  Error bars are 1 SEM.  n=3 for 
each molar ratio. 
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crystallins.  Finally, the protein can inhibit amyloid fibril formation of BAP under the 
conditions tested and is most effective in sub-stoichiometric amounts. 
Although sequence homology is relatively low, there is very significant 
secondary structural similarity between HSP20 and the two α-crystallins depicted in 
Figure 8.  The large majority of beta sheets are seen in the predicted α-crystallin region 
for all three proteins.  The residue Arg 108 was identified as very important to the 
function of wheat 16.9 (6).  In fact, it is one of the most highly conserved residues in all 
α-crystallins.  The sequence alignment shows that this amino acid is conserved in 
HSP20 as well in the form of residue 134.  The residue is also present in the M. 
jannaschii homolog as Arg 107.  It is speculated that this residue is important in 
assembly modes of the multimers thus relating quaternary structure to function (6). It is 
pointed out by Sun et al. (1) that residues 83 to 105 of wheat 16.9 are very important in 
dimerization of the protein as evidenced by x-ray crystal structure.  This area of 
HSP16.9 is aligned to regions of high secondary structure homology within M. 
jannaschii HSP16.5 and HSP20 (Figure 8).  Leucine 122 of M. tuberculosis HSP 16.3 
which is equivalent to Leu 116 in B. japonicum HspH, was shown to be of great 
importance to the function of the protein.  This is in the highly conserved region of 
GVLTVTV seen in most -crystallins (64, 65).  The equivalent residue is observed in 
HSP20 as well at residue 157, residue 129 of M. jannashcii and 130 of wheat HSP 16.9.  
These residues were shown to be paramount to function and affected the oligomerization 
of HspH and M. tuberculosis HSP 16.3 (64, 65).  Several conserved residues within 
known α-crystallin domains are observed in the proposed α-crystallin domain of HSP20. 
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The amino and carboxy terminal regions are quite divergent in the α-crystallins.  
However, there is still significant homology observed in Figure 8 in these terminal 
regions.  The functions of these regions are explored more thoroughly in the next 
chapter.  The N-terminus is generally an unstructured and often solvent exposed region 
of the protein containing many hydrophilic residues.  Little secondary structure has been 
assigned to the N-termini of the three proteins in Figure 8.  The C-terminus has a fairly 
well conserved V/IXI/V motif present in the last 20 amino acids of many sHSP’s.  This 
small sequence is visible in HSP20 at position 158 to 160.  The motif is observed at 
position 143-145 in M. jannashcii and 147-149 in wheat hsp 16.9 (Figure 8). 
As the name implies, heat shock proteins are active during times of environment 
stress that could include, but is not limited to a temperature change in the environment of 
the organism.  In order to be active, the proteins must be stable over a wide temperature 
range.  The circular dichroism spectra in Figure 10 display the stability of HisHSP20 
over such a range of temperatures.  Even at the extreme temperatures of 5 and 95°C, 
much of the native secondary structure signal remains.  Thus, HSP20 appears to have the 
stability needed to function as a molecular chaperone during times of environmental 
insult to the host.  In fact, the protein was shown to be upregulated during environmental 
changes including temperature increase and oxidative stress (Ficht unpublished). 
Many of the above conserved regions and residues affect the oligomeric makeup 
of the sHSP’s.  It is shown in Figures 11 through 16 that HisHSP20 forms very large 
multimers.  In fact, these multimers are as large and diverse in population as to make 
their characterization problematic.  By manipulating the solution conditions, the 
population distribution of multimers was altered (Figures 13-15).  This dynamic 
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multimerization is another commonality between HSP20 ant the α-crystallin sHSP 
family. 
Though it does have structural and stability attributes similar to other α-
crystallins, the question of similar activity to other members of the sHSP family 
remained.  This question is addressed in the final set of experiments in this chapter.  The 
activity of HisHSP20 against thermal denaturation of ADH was illustrated in Figures 17 
and 18.  Several molar ratios of HisHSP20 to ADH were tested.  The most effective 
ratios were found to be equimolar in nature.  The apparent light scattering (and thus the 
thermal aggregation of ADH) increases as the concentration of HisHSP20 decreases to a 
molarity less than that of ADH.  This is in stark contrast to the results of 
amyloidogenesis inhibition by HisHSP20.  In Figure 19, the full-length protein is shown 
to inhibit amyloid fibril formation most effectively at substoichiometric amounts.  In 
fact, this same protein was shown by Lee et al. to inhibit amyloid fibril formation at very 
low substoichiometric levels of 1:1000 to 1:100,000 of HisHSP20 to ADH (27).  In this 
particular set of experiments, the protein is still most effective at a molar ratio of 1:10 
(HSP20: BAP) and was actually least effective at a molar ratio of 1:1.   
In conclusion, it has been proven that HSP20 does share many structural 
commonalities with other known -crystallin sHSP’s.  In addition to these physical 
similarities, the protein also behaves as known sHSP’s under the conditions tested 
above.  At this point, it remained to be seen if these activities and structural attributes 
could be modified by altering the domains thought to be responsible for multimerization.  
The creation and analysis of these deletion mutants and their activities is evaluated in the 
next chapter. 
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CHAPTER IV 
DEVELOPMENT AND STUDY OF TRUNCATION MUTANTS OF HSP20 
Introduction 
Though quite divergent in sequence among the small heat shock protein family, 
many have shown the N and C termini to be of varying importance to proper assembly 
and function of many sHSP’s. (17, 33, 61, 66-75).  The N-terminus is often exposed to 
solvent and largely unstructured.  This region of the α-crystallins often undergoes rapid 
hydrogen/deuterium exchange.  A common technique used to examine the importance of 
the N-terminus for a particular sHSP is to delete portions of the region and analyze its 
effects on multimeric assembly and chaperone function.  This has been done for many 
α-crystallins with a wide variety of results.  An example cited is that of the rat αA-
crystallin.  Deletion of its N-terminus yields a protein with a greatly decreased activity 
that only assembles into dimers and tetramers (76).  In contrast, Laksanalamai reported 
that deletion of the N-terminal region of their α-crystallin isolated from P. fuiriosus had 
no affect on multimerization or chaperone activity while a deletion of both the N and C 
termini drastically affected both activity and oligomerization (5). 
In the following results, we describe the multimerization and chaperone activities 
of three deletion mutants of HSP20.  These mutants were designed to exhibit altered 
multimerization profiles from that of HSP20 by deleting the N and C termini and 
keeping the proposed α-crystallin domain intact. 
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Results 
Structural Studies of Truncated Forms of HSP20 
A sHSP from the hyperthermophile P furiosus(Pfu-sHSP) has been studied and 
characterized by Laksanalamai (5).  Unlike the two previously mentioned α-crystallin 
sHSP’s from wheat and M. jannaschii, this protein forms a polydisperse array of 
multimers in solution similar to that observed with HSP20 as shown in Chapter III.  By 
examining the known crystal structure of the M. jannaschii HSP 16.5, Laksanalamai and 
van Montfort noted that the extended carboxy terminus was responsible for contact 
between dimers (5, 6).  Laksanalamai also showed that by deleting the N and C termini 
of their sHSP, the multimeric state of the protein could be altered (5).The researchers 
concluded, however, that the N-terminus was “dispensable” for multimeric assembly, 
unlike the αA-crystallin from rat discussed earlier (76) which displayed a tendency 
towards aggregation and displayed reduced chaperone activity after deletion of its N-
terminus.  Laksanalamai generated two mutants.  The N-terminal 52 amino acids were 
deleted in one mutant (PfuN52) and the N-terminal 52 amino acids along with the twelve 
carboxy terminal amino acids were deleted in the other mutant (PfuN/C).  These regions 
were determined by sequence alignments of the P. furiosus HSP with M. jannaschii 
HSP16.5 (5).  Using techniques such as SEC and SDS PAGE analysis of cross-linked 
samples, the researchers showed that the PfuN/C was only capable of forming dimers and 
had a markedly reduced thermal protection activity.  The deletion of the 52 amino acids 
from the N-terminus (PfuN52) resulted in no change in activity and a more polydisperse 
population of multimers (5).  However, the authors of this study did not report on the 
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behavior of a deletion mutant of only the C-terminal amino acids thought to be involved 
in inter-dimeric contacts.   
 
 
HSP20 1 -MSCIMRCNNAD-QEVIIDEQTGLPIKSHDYSEKPSVIYKPSTTVPQNTL
Pfu 1 MVRRIRRWDIWDPFDLIREIQEEIDAMFDEFFSRPRLWTYRRWSEPA---
HSP20 49 LEIPPPKELENPITFNPTVDTFFDADNNKLVLLMELPGFSSTDINVECGW
Pfu 47 ----MYEERVGEVWREPFVDIFDNGD--EFVITAELPGVRKEDIKVRVTE
HSP20 99 GELIISGPRNKDELYEKFGNNLDIHIRERKVGYFYRRFKLPNNAIDKSIS
Pfu 92 DTVYIEATVKREKELEREG---AVRIERYFTGYR-RAIRLPEEVIPEKAK
HSP20 149 VGYSNGILDIRIECSQFSEMRRVQIDAKA-
Pfu 138 AKYNNGVLEIRVPKKHPTKKESEGFEVKVE
 
Figure 20  Sequence alignment of HSP20 and P furiosus sHSP (Pfu) (2).  Alignment 
used to determine potential regions involved in multimer formation.  Alignment 
performed using ClustalW 1.82 plugin of BioEdit Software.  Residue number and 
protein indicated on left; (-) no residue.   
 
 
Figure 20 is a sequence alignment of HSP20 with the sHSP from P. furiosis 
identified by Laksanalamai (5).  From this alignment it was determined that deletions of 
the last 11 and the first 50 amino acids from HSP20 could affect the multimeric state of 
the protein.  Three truncations of the protein were created.  Using primers designed to 
anneal within the coding region of the HSP20 gene, truncated forms of the coding region 
were amplified using PCR and ligated into an inducible expression vector as described in 
Chapter II.  The truncated forms of HSP20 protein were expressd and purified in the 
same manner as full-length HisHSP20 (ChapterII).  The three truncated forms are an N-
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terminal deletion of 50 aa (NHisHSP20), a C-terminal deletion of 12 aa (CHisHSP20), 
and a deletion of both the N-terminal 50 aa and C-terminal amino acids (NCHisHSP20).  
These deletions were made in regions that were not part of the α-crystallin domain; 
however, the structure/activity of the protein could easily be altered or destroyed by such 
deletions.  Approximately 36% of the full-length form is deleted in the N- and C-
terminal deletion.  Table 4 contains basic chemical information for the three deletion 
mutants. 
 
 
 
Table 4:  Basic chemical parameters of HisHSP20 deletion mutants 
Protein Number of Amino 
acids 
Molecular 
Weight 
Theoritical 
pI 
Extinction 
Coefficienta 
C-terminal 
deletion 
CHisHSP20 
208  (11 C-
terminal aa’s 
deleted) 
23,598 Da 5.01 17670 
N-terminal 
deletion 
NHisHSP20 
169 (50 N-
terminal aa’s 
deleted) 
19,277 Da 5.29 14565 
N- and C-
terminal 
deletion 
NCHisHSP20 
158 (11 C-terminal 
and 50 N-terminal 
aa’s deleted) 17,978 Da 5.12 14565 
a
 Extinction coefficient is in units of  M-1 cm-1, at 280 nm assuming all Cys residues 
appear as half cystines 
 
 
Structural Studies of HSP20 Truncation Mutants 
Because of these deletions, the secondary structure and stability could be greatly 
affected.  Below is a figure showing the CD spectra of the three deletion forms at various 
temperatures (Figure 21).  Noted immediately was the fact that the mutants lose very 
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little of their secondary structure over the temperature range of 5 to 95°C.  This is what 
was observed for the full-length form (Figure 10).  Another point of interest is the 
secondary structure of the mutants themselves.  The spectra of CHisHSP20 are almost 
identical to that of the full-length version.  However, the two N-terminal deletion 
mutants have identical spectra to each other, but are different from the spectra for the 
Full-length and C-terminal deleted forms.  The spectra have a strong beta sheet signal 
that is actually more centered at the typical absorbance at 217 nm than the spectra of 
either the full-length form or CHisHSP20.  In Figure 8, it was observed that the N-
terminal fifty amino acids of HSP20 had little secondary structure.  It is likely that 
removing this region of the protein (as was the case with the two N-terminal deletion 
mutants) caused a loss of the random coil CD signal from that region.  This allowed the 
predominantly beta sheet secondary structure that remained to be clearly visualized by 
CD. 
Studies of the Multimeric Forms of Truncated Versions of HSP20 
The deletions made in HisHSP20 were designed to alter the multimeric 
population of the protein in solution.  As with the full-length form of HisHSP20 in 
Chapter II, glutaraldehyde cross-linking was employed to capture multimeric forms of 
the deletion mutants for comparison to the multimeric forms observed for the full-length 
form.  Samples of the protein were exposed to the cross linking agent for up to 20 
minutes.  After quenching the cross-linker with glycine, the samples were examined 
using SDS PAGE and western blotting or size exclusion chromatography under 
denaturing conditions.  
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Figure 21  Far UV CD Spectra of 29 µM samples of C-terminal deletion HSP20 (CHisHSP20), N-terminal deletion HSP20 (NHisHSP20) 
and NC deletion HSP20 (NCHisHSP20) in 10 mM phosphate, 120 mM NaCl from 5 to 95°C.  Samples were equilibrated at each 
temperature for 5 minutes prior to reading.  Path length was 1 cm 
 
  
65 
25
100
29
14
66
HisHSP20       CHisHSP20   NHisHSP20    NCHisHSP20
0      10     20     0     10    20     0    10    20     0     0   20
 
Figure 22  Western blot of cross-linked samples of HisHSP20 and its deletion mutants.  
Equimolar samples were equilibrated at room temperature prior to glutaraldehyde cross-
linking.  Cross-linker was quenched at 0,10 and 20 minutes and samples of each time 
point (indicated by labels below lanes)were separated on a 4-20% gradient SDS PAGE 
gel.  Kaleidoscpoe marker (BioRad) is shown in left-hand lane with molecular weights 
in kDa.  Samples were blotted to nitrocellulose membrane and probed using antiserum 
raised against HSP20 as described in Chapter II. 
 
 
 
Figure 22 is a western blot depicting the 4 forms of the protein generated in this 
study after exposure to 0.01% glutaraldehyde for 10 and 20 minutes at room 
temperature.  It was immediately evident that the C-terminal deletion of HSP20 results 
in a lesser degree of multimerization, but does not eliminate multimerization as 
evidenced by the 0 time point in Figure 22 for CHisHSP20.  Deletions in the N-terminal 
deletions results in no multimers larger than a dimer at any appreciable levels. 
  
66 
HisHSP20    CHisHSP20 NHisHSP20 NCHisHSP20
0  10 20    0     10    20     0   10 20 0 10 20
250
150
100
75
50
37.5
25
20
 
Figure 23  SDS PAGE (4-20% gradient) separations of cross-linked samples of 
HisHSP20 and its deletion mutants.  Equimolar samples were equilibrated at room 
temperature prior to glutaraldehyde cross-linking.  Cross-linker was quenched at 0, 10 
and 20 minutes and samples of each time point (indicated by labels below lanes) were 
separated on a 4-20% gradient SDS PAGE gel.  Broad Range Precision Molecular 
weight Standards (BioRad) is shown in left-hand lane with molecular weights in kDa.  
Arrows indicate dimeric forms of each protein.  Stained with SYPRO Ruby stain 
(BioRad) and visualized by fluorescence from exposure to 280 nm light. 
 
 
Figure 22 illustrates the fact that electrophoresis in the presence of SDS is not sufficient 
to destroy the natural multimeric formations of the proteins.  This is especially evident in 
the cases of the full-length and CHisHSP20 forms. Note at the 0 time points for both, 
where no cross-linking agent was added, the multimers are clearly visible on the blot.   
Unfortunately the polyclonal antiserum used in the above western blot does not have the 
same affinity for the two N-terminal deletion mutants.  Very little staining of these 
proteins is seen even after a longer incubation time with antibody.  To visualize the 
protein throughout the gel, it was stained with SYPRO Ruby stain as shown in Figure 
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23. The use of this fluorescent stain allows visualization of the larger multimeric species 
not seen in previous Coomassie stained samples (Figure 11).  It is clearly seen in Figure 
23 that the full-length form of HisHSP20 and CHisHSP20 form much more of these 
large species (100 kDa and above) than the two N-terminal deletions.  The same molar 
amounts of proteins were placed in each well and the cross-linking was performed on 
identical concentrations of proteins in identical volumes.   
By using a denaturant such as guanidinium hydrochloride, all tertiary and 
quaternary structure was destroyed leaving only those multimers that were covalently 
cross-linked by glutaraldehyde.  The cross-linked multimers were analyzed by separation 
via SEC in the presence of 6M guanidinium HCl.  As can be seen in Figure 24, the 
truncated forms of the protein exhibit a reduced tendency to form multimers.  HisHSP20 
not exposed to the cross-linker eluted from the S200 column at 21.5 ml (corresponding 
to the monomeric form) under denaturing conditions.  The next peak at 16.5 ml 
corresponds to an intermediate multimer.  The final peak is located in the void volume of 
the column and corresponds to a very large (greater than 600 kDa) species.  The inset 
allows for greater visualization of the two smaller elution peaks of interest.   
In Chapter III, size exclusion chromatography was used in an effort to analyze 
the multimeric forms of the protein under native conditions.  However, the majority of 
the protein was not seen in the eluted volume of the column unless very low 
concentrations of proteins were applied to the column (Figures 13-15).  Because the 
deletions of the N and C termini of HSP20 altered the oligomeric equilibrium of the 
proteins from that of the full-length form, the elution profile of the truncated forms 
would also be different. 
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Figure 24  Elution profiles of full-length HisHSP20 and its deletion mutants from a 
Superdex 200 column.  Samples were cross linked with glutaraldehyde for 10 minutes 
after equilibration at room temperature prior to separation on the column.  Mobile phase 
contains 6M guanidinium hydrochloride, 10 mM phosphate, 120 mM NaCl pH 7.4.  
Void volume of 9.81 ml is indicated in figure 
 
 
 
In Figure 25, the Superose 6 10/300 GL column used to analyze the full-length protein 
was employed to examine the truncated forms of the protein.  A very different profile of 
elution was observed from that of the full-length form of the protein.  A peak eluting at 
the apparent molecular weight of a dimer(~20.2 ml) was seen in a much greater amount 
for all three deletion mutants than that observed for the full-length version of HisHSP20 
(Figures 13-15).  By measuring the area under this curve and comparing it to the total 
absorbance of an equimolar sample at 280 nm, it was estimated that approximately 50 to 
75% of the total protein had eluted from the column for the two C-terminal deletion 
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mutants.  The N-terminal deletion mutant had a smaller dimeric elution peak (about 20-
30% of the protein eluted).  It is also interesting to note that a peak corresponding to a 
large molecular weight is seen in the case of the N-terminal deletion mutant.   
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Figure 25  Elution profile of HSP20 deletion mutants from a Superose 6 10/300 column.  
Samples at 29 µM eluted largely as a single peak corresponding to molecular weight of a 
dimer for each mutant relative to size exclusion standards indicated at top of graph:  
thyroglobulin(669 kDa), ferritin (440 kDa), aldolase (158 kDa) and lysozyme (14.4 
kDa).  Void volume is indicated for the column at 7.81 ml.  Mobile phase and sample 
buffer was 10 mM phosphate, 120 mM NaCl pH 7.4 
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This peak corresponds to a very large species as it eluted before the void volume of the 
column and was not observed every time this experiment was performed.  The C-
terminal deletion mutants showed no such peak.  
Again, much of the protein is not seen using SEC.  Therefore, the total 
population was visualized using a glycerol gradient as described before with the full-
length form of HisHSP20 (Chapter III).  The proteins were radiolabeled with 35S-
methionine and purified.  They were placed on a 5-30% glycerol gradient and spun for 
48 hours at 150,000xg (Figure 26).  As in the case of the CD spectra of the various 
forms, CHisHSP20 displayed a very similar profile to that of the full-length form of the 
protein with one peak centered at fraction 12.  The two N-terminal deletion mutants have 
very similar profiles to one another, but are very different from HisHSP20 and 
CHisHSP20.  In this case, the gradients had two regions of protein density.  The peak 
near the center of the gradient (fractions 10 to 17) is still present for both forms of the 
protein.  However, these peaks were smaller and broader than those observed for the C-
terminal deletion.  Also, there was much more signal at the bottom of the gradient 
corresponding to pelleted protein and possibly insoluble HSP20. 
 Elution at fraction 12 resulted in a calculated sedimentation coefficient-value of 
7 and an apparent molecular weight corresponding to that of a heptamer (141 kDa) of the 
CHisHSP20 proteins.  This is very similar to the result obtained when the full-length 
version of the protein was exposed to this gradient in Chapter III (Figure 16).  The 
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Figure 26  Elution profile of 35S radiolabeled HisHSP20 deletion mutants from a 5-30% 
glycerol gradient.  Samples were centrifuged at 150,000 xg for 48 hrs. at 4°C.   Fractions 
were collected from bottom of gradient and radioactivity was read via scintilitation 
counting.  Percentage of total counts for each sample is plotted vs. fraction number.  
Molecular weight standards of ferritin (fraction 4-440 kDa) and bovine serum albumin 
(fraction 14-66 kDa) were detected by absorbance of each fraction at 280 nm in a 
separate gradient ran under the same conditions 
 
  
leading edge of the CHisHSP20 peak (fraction 10) has an apparent molecular weight of 
~200 kDa (a decamer) and an S-value of 11.  
Activities of Truncated Forms of HSP20 
How do these deletions affect the activity of the proteins with respect to their 
ability to inhibit aggregation?  Using the ADH light scattering technique described in 
Chapter II, it was shown that the proteins have the same level of specific activity as the 
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full-length form of the protein (Figure 27).  The results of light scattering inhibition by 
the full-length form are included in the figure below for comparison.  Equimolar ratios 
of HisSHP20: ADH were most effective in inhibition of the thermally-induced 
aggregation of ADH under the conditions tested.  All proteins displayed an equal 
specific activity against this thermal aggregation.  Thus, activity of the protein is not 
measurably affected by deletion of the N and C termini despite the effects on 
multimerization observed for the deletion mutants.  
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Figure 27  Apparent light scattering of ADH in the presence of different amounts of 
HisHSP20 forms.  The concentration of ADH is kept at 3.25 E-6 M. Molar ratios of 
HisHSP20 form to ADH are indicated on x-axis.  Samples were incubated for 20 
minutes at 58°C prior to measuring absorbance at 360 nm.  Absorbance of each sample 
was compared to absorbance of a sample of ADH alone.  The percentage of absorbance 
compared to that of the ADH standard is plotted on the y-axis for each molar ratio.  
Error bars are 1 SEM.  n=3 
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Though the inhibition of thermally-induced aggregation is unchanged after 
deleting the N- and C-termini, the inhibition of amyloid fibril formation by Aβ(1-40) 
(BAP) must be evaluated for the deletion mutants.  Figure 28 depicts the Congo red 
binding of solutions of BAP with varying molar ratios of the three truncated forms of the 
HisHSP20 protein. 
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Figure 28  Inhibition of amyloid fibril formation by HisHSP20 forms.  Samples of Aβ(1-
40) (50 µM) were incubated at room temperature for 24 hours alone or in the presence of 
different amounts of HisHSP20 or deletion mutants of HSP20.  Molar ratios of HSP20 
forms to Aβ (1-40) are indicated on x axis.  Samples were analyzed by Congo red binding 
as described in Chapter II.  Congo red binding was used to calculate amount of fibrils 
formed using equation 1. Amount of fibrils formed in each sample was compared to 
amount of fibrils in a sample of Aβ (1-40) alone.  The percentage of fibrils compared to 
that of the Aβ (1-40) standard is plotted on the y-axis for each molar ratio.  Error bars are 1 
SEM.  n=3 for each molar ratio. 
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Again, for comparison, the full length results were included in the figure.  The 
only molar ratio that showed a statistically different Congo red binding result is the 1:10 
molar ratio of HSP20 to BAP.  A one-way ANOVA at the 95% confidence interval 
resulted in a p-value of <0.05 when comparing the 1:10 molar ratio of all protein forms 
to BAP alone.  Thus, the inhibitory activity of HSP20 against amyloid fibril formation is 
conserved despite deletion the N and C termini.  
Summary and Discussion 
It was not clear what roles if any the 50 amino acids in the N-terminus and the 11 
amino acids of the C-terminus of HSP20 played.  Others have analyzed the equivalent 
regions of other α-crystallins and seen that these regions are crucial for multimerization.  
Some have shown that these regions are also important for the function of the protein in 
inhibition of aggregation of partially unfolded proteins (5, 76).  Thus it seems that these 
regions differ in their importance and function from one α-crystallin to the next.  It was 
important to establish the roles of these domains within the activities and 
multimerization of HSP20.  Deletion mutants were created based on sequence 
alignments with a well-characterized α-crystallin (5).  Laksanalamai et al. reported that 
the sHSP isolated from the extremophile P. furiosus exhibited a wide range of 
multimeric species similar to our findings for HSP20 (5). 
The authors created deletion mutants based on a visual analysis of the crystal 
structure of the M. jannaschii HSP16.5.  They reasoned that the C-terminal 12 amino 
acids of M. jannaschii were responsible for the interdimeric contacts during assembly of 
the monomers into oligomers.  Upon deletion of both the C-terminal 12 amino acids and 
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the N-terminal 52 amino acids, the authors reported a loss of all quaternary structure 
above a dimer (5). 
  The authors reported a diminished protection against thermally-induced cell 
death of E. coli cells producing the truncated form of the sHSP compared to cells 
producing the full-length protein.  Laksanalamai concludes that the C-terminus is 
responsible for subunit assembly and that multimerization is crucial for function as the 
deletion mutant that did not form large multimers showed decreased activity against 
thermally-induced cell death.  They also concluded that the N-terminal region is not 
needed for multimeric assembly (5). However, in that publication, there were no 
published results for a form of the P. furiosus HSP with the C –terminal amino acids 
corresponding to the oligomerization domain deleted (5) 
A primary sequence alignment of HSP20 with the sHSP from P. furiosus 
revealed regions that corresponded to the domains attributed to multimer assembly 
identified by Laksanalamai (5).  However, when these deletions were made in HSP20, 
the effects on multimerization and activity were different than those observed by 
Laksanalamai and Merk (αA-crystallin from rat) (76).  In the case of HSP20, the 
multimeric population was altered when either the N-terminal or C-terminal domain was 
deleted.  A much larger percentage of the protein existed as dimer (up to 70% as 
evidenced by SEC in Figure 25), but higher order complexes still existed (as shown by 
the sedimentation velocity experiment in Figure 26 and the western blot in Figure 22) 
especially for the C-terminal deletion mutant.  The authors of the study on P. furiosus 
concluded that the N-terminal region was not necessary for multimeric assembly as 
polydisperse forms were still visible after glutaraldehyde cross linking of the N-terminal 
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deletion mutant (5).  However, we have shown that a deletion of the 50 amino acids 
from the N-terminus of HSP20 results in a significantly reduced amount of multimeric 
assembly.  The authors of the previous study did not test a form of the protein with only 
the C-terminal domain deleted.  Here, we report on such a deletion mutant.  It was 
shown that deleting the eleven C-terminal amino acids of HSP20 markedly reduces, but 
does not eliminate, multimeric forms of the protein.  The double deletion 
(NCHisHSP20) still shows the presence of multimeric forms as evidenced in the 
sedimentation velocity experiment (Figure 26), but shows even less multimerization than 
that of the C-terminal deletion.  The glutaraldehyde cross linking performed on the P. 
furiosus sHSP N-terminal deletion mutant resulted in an altered multimeric profile, but 
still showed multimers larger than dimer (5).  In the case of HSP20, nothing larger than a 
dimer formed after cross-linking the N-terminal deletion mutants. 
Others have reported that the N-terminal region of the sHSP’s is generally 
unstructured.  Thus, the deletion of the N-terminal fifty amino acids has likely resulted 
in decreased solubility of the protein.  In fact, it was found that during the purification 
process the N-terminal deletion mutants were less stable when stored at 4°C over a 
period of days as the samples became turbid (unpublished observation).  There was more 
protein at the bottom of the sedimentation velocity gradient for the N-terminal deletion 
mutants (Figure 26).  This likely corresponds to aggregation of the protein caused by 
decreased solubility.  Another indication of this lack of structure in the N-terminus is 
revealed in the CD spectra of the deletion mutants.  All three mutants are very stable 
over the temperature range tested (5-95°C) just as the full-length protein behaved 
(Figure 10).  The spectra of CHisHSP20 are very similar to those for the full-length 
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form.  But the N-terminal deletion mutants have a different set of spectra (Figure 21).  
These spectra are shifted to the region corresponding to beta sheet and away from the 
region typical of unstructured proteins.  This correlates quite well with the hypothesis 
that the N-terminus of HSP20 is largely unstructured.  The secondary structure 
prediction software used in Figure 8 attributed very little secondary structure to the N-
terminus of HSP20.  Thus, when this unstructured region is deleted, the strong beta sheet 
signal generated as a result of the α-crystallin domain is no longer masked by the signal 
of the unstructured N-terminus and the spectra appears to shift to a more beta-sheet-like 
spectrum. 
Despite deleting up to 35% of the protein (in the case of NCHisHSP20) and 
altering the multimeric state, the truncated forms displayed an identical activity against 
both thermal denaturation (Figure 27) of ADH and amyloid formation of BAP (Figure 
28).  In the case of the rat αA-crystallin studied by Merck et al. (76), a deletion of the 
multimeric domains not only causes arrest of multimeric assembly at the dimeric form, it 
also destroys the aggregation protection observed for the protein.  Laksanalamai reported 
the double deletion of the two termini of the P. furiosus sHSP resulted in a greatly 
reduced viability of cells expressing the truncated form while incubating at elevated 
temperatures as opposed to cells expressing the full length version (5). 
Though multimeric assembly is quite divergent among sHSP’s, the dimer is 
always obsreved.  This has been shown to be a result of interactions between two α-
crystallin domains of two separate monomers (6).  The larger quaternary structures vary 
between sHSP’s with some showing a monodisperse population while others display a 
polydisperse one (5, 6, 14).  Some disassemble at elevated temperatures (6).  The work 
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in this dissertation shows that under the testing conditions used above, multimeric 
assembly has no bearing on the inhibition of aggregation of proteins by HisHSP20.  
However, the dimeric form of the protein is still seen.  We are left to conclude that the 
α-crystallin domain is the source of this inhibition of aggregation.  This is of great 
interest because the role of multimerization of α-crystallin sHSP’s in function has been a 
central question in the field.  This ability to form large dynamic structures may serve a 
purpose in vivo not observed in these experiments. 
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CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 An organisms ability to survive is based largely on its ability to adapt to 
environmental changes.  The protein complement of a cell can be altered greatly due to 
relatively slight changes in the host’s environment.  This coupled with the spectrum of 
possible folds an individual protein can attain creates a formidable challenge for the life 
of the host.  Organisms have developed many tools to assist them in surviving in an 
ever-changing environment such as the heat shock proteins.  Within these groups of 
proteins are the α-crystallins.  This diverse group has a common α-crystallin domain and 
often forms multimers.  They function in chaperoning partially-unfolded proteins and 
preventing interactions with other proteins that might lead to aggregation and eventual 
loss of function. 
 Here, we investigate a novel protein isolated from Babesia bovis that shares 
homology with the α-crystallin family of sHSP’s.  HSP20 forms multimeric complexes 
from a single type of monomer as is the case for members of the α-crystallins (Figures 
12-16).  It has been shown here that HSP20 inhibits the aggregation of alcohol 
dehydrogenase at elevated temperatures at stoichiometric levels (Figures17 and 18).  
Finally, it has been shown to inhibit amyloid fibril formation at a sub-stoichiometric 
level, but not at an equimolar ratio (Figure 19). 
 Though sequence homology is limited, the predicted secondary structure for 
HSP20 is very similar to other sHSP’s studied as shown in Figure 8.  The region of 
greatest similarity is found to be within the proposed α-crystallin domain of the protein.  
Also, there are conserved residues within the sequence of HSP20 that correspond to 
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those residues found to be crucial to the function of other α-crystallins.  HSP20 often 
forms large multimers in solution that are visible even when using SDS PAGE.  In the 
case of HSP20, these multimeric species are a broad polydisperse group of multimers.  
Some α-crystallin sHSP’s form discrete populations of multimers such as HSP16.5 from 
M. jannaschii (14),while others form a range of multimeric species under a given set of 
solution conditions such as the HSP fro P.furiosus studied by Laksanalamai et al (5). 
 Through sequence alignments and crystal structures, others have proposed 
models of α-crystallin multimeric assembly.  Generally, the α-crystallin domain itself is 
thought to be involved in dimer formation, while the N and C termini are thought to be 
involved in higher-order assembly (6, 14).  Deletion mutants of HSP20 were generated 
in an effort to gain a better understanding of its multimeric assembly.  Using SEC, it was 
found that the capability of HSP20 to oligomerize was altered when the C-terminal 11 
amino acids were deleted.  The N-terminal domain has been shown to play a varying 
role in the multimerization of α-crystallins. It was observed by  van Montfort through  
analysis of the x-ray crystal structure of HSP16.9 from wheat that the N-terminus of one 
monomer in a dimer was unstructured while the amino region of the other monomer was 
structured and found to be interacting with another monomer of a different dimer and 
was thus contributing to the stability of a large multimeric form of the protein (6).  In the 
case of Laksanalamai, the N terminus of the sHSP from P. furiosus was shown to have 
little effect on multimerization (5) while Merck et al. showed that deletion of the N-
terminus resulted in only dimer formation and a loss of aggregation protection activity in 
an α-crystallin isolated from rats (32, 76).  A deletion of the first 50 amino acids of 
HSP20 did alter the multimeric nature of the protein but had no affect on its chaperone 
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activity.  In Chapter IV, the proportion of NHisHSP20 multimeric forms observed at 
equilibrium are dramatically reduced as evidenced by various separation techniques such 
as SEC and electrophoresis (Figures 22-26).  However, from the techniques used above, 
it is not clear if the same interactions between full-length monomers are preserved in the 
truncated forms.  
As mentioned earlier, the C-terminus is thought to be responsible for interdimeric 
contacts, which would result in a multimeric intermediate.  However, in the case if 
HSP20, we have shown that deletion of the N-terminus also results in the loss of this 
intermediate multimer as it was absent from the cross-linked sample separated by SEC 
under denaturing conditions (Figure 24).  Thus, we propose that the N-terminus is 
crucial for multimeric assembly of HSP20 as well.  This activity may be direct in the 
case of the N-terminus acting as a recruitment domain for smaller species (monomers 
and dimers) allowing these species to interact and align is a way that resulted in proper 
C-terminal contacts.  This phenomenon could also be an indirect effect in that the 
structure of the protein was altered when the N-terminus was absent and thus the proper 
orientation to form multimers was attained.  Finally, the N-terminus could simply be 
affecting the solubility of the protein.  Certainly, it was observed that over time at a low 
temperature (4°C) the protein aggregated and fell out of solution.  This is also observed 
in velocity sedimentation analysis in glycerol gradients.  In the case of the N-terminal 
deletions, a larger fraction of the protein applied to the gradient was present at the 
bottom of the gradient suggesting aggregation during the course of the separation (which 
was performed at 4°C for 48 hours and is shown in Figure 26).  Therefore, if the N-
terminus is responsible for solubility of the protein, its absence could preclude the 
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formation of ordered multimers simply by disallowing proper folding and interactions to 
occur under the solution conditions.  The phenomenon of the N-terminus playing a large 
role in the multimeric assembly of a sHSP is not without precedent.  Leroux et al. 
showed that the N-terminal domain of HSP 16.2 from C. elegans  was needed to form 
multimers larger than a dimer (8) and Merck showed loss of both oligomeric assembly 
and chaperone function resulting from a deletion of the N-terminus of their sHSP from 
rat (32, 76).  A model which encompasses our observations of multimeric assembly is 
presented in Figure 29.  
It has been shown that HisHSP20 inhibits the aggregation of ADH in solution at 
elevated temperatures, as many others have shown for other members of the α-crystallin 
family(1, 11).  The greatest protection against thermally-induced aggregation of ADH 
was seen when equimolar amounts of HisHSP20 were present.  This is in agreement 
with the observations of Horwitz and others with respect to protection against thermally 
induced aggregation by α-crystallins.  Interestingly enough, the deletion mutants have 
no discernable effect on this activity.  The three deletion mutants are equally capable of 
inhibiting aggregation of ADH under the conditions tested and are just as effective as the 
full-length version of HisHSP20 (Figure 27).  Thus, it is likely that the α-crystallin 
domain is necessary and sufficient to maintain this activity.  
The amyloidoses have garnered much attention of late.  Researchers are actively 
investigating several methods of dealing with this devastating class of diseases.  There 
has been a great deal of focus on the mechanism of amyloid fibril formation and how to 
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prevent it.  Many research efforts have resulted in molecules that can inhibit amyloid 
fibril formation in vitro at equimolar ratios (77-79).  Pallito et al. showed that a small 
peptide can inhibit fibril formation (79).  Others have shown varied results with respect 
to α-crystallins’ effectiveness against amyloid formation and toxicity in vitro (22, 34-36, 
79).  Santhoshkumar et al. developed a 19 amino acid peptide based on a portion of the 
α-crystallin domain that inhibits fibril formation but only at equimolar concentrations of 
Figure 29  Model of possible oligomerization pathway of HSP20.   A stable 
dimer is formed through interaction between α-crystallin domains (A) N-
terminal domains could act as recruiting factors bringing dimers in closer 
proximity and proper alignment(B) for stable intermediate formation(C) leading 
to superstructure formation (D). 
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the fibril forming protein/peptide(80).  Here, we report on a protein that can inhibit 
amyloid fibril formation of the Beta Amyloid Peptide and does so at a substoichiometric 
ratio.  Lee and Carson (27) reported on the activity of this protein in the  inhibition of 
amyloid fibril formation by the Aβ(1-40) peptide over a wide concentration range 
corresponding to molar ratios of 1:1000 to 1:100000 of HIsHSP20 to Aβ.  It was 
reported in that same publication that the toxicity of Aβ towards neuronal cells in culture 
was reduced when HisHSP20 was present at these levels. 
We report in Chapters III and IV that HisHSP20 and the three truncated forms 
can inhibit amyloid fibril formation of 50 µM Aβ(1-40) at a molar ratio of 1:10.  Perhaps 
what is most impressive is the fact that despite deleting up to 35% of the protein, the 
specific activity of amyloid inhibition is unaffected under the conditions tested.  Though 
the concentration range of HSP20 where protection is seen is different from the earlier 
work of Lee and Carson, the trend of protection at a substoichiometric level is still seen.   
Also in this study, it was seen that at a molar ratio of 1:1 of HisHSP20 to Aβ, no 
protection was seen and in most cases, amyloid formation was greater when an 
equimolar amount of HisHSP20 was present (Figure 28).  This trend was seen in Lee 
and Carson’s earlier work in that as concentration of HisHSP20 increased (i.e. the molar 
ratio increased towards 1:1), the protection lessened.  Therefore, we propose that the 
active form of HisHSP20 protein is interacting with a multimeric intermediate of Aβ.  
Because the multimeric form of HisHSP20 likely changes with its concentration, we 
conclude that at higher concentrations, the protein forms a multimer that does not allow 
productive interaction with Aβ intermediates.  This is likely a result of accessible active 
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sites being blocked when HSP20 in in larger multimeric assemblies.  Our results suggest 
the amount of active form of HSP20 was not altered by the changes in multimeric 
assembly introduced by the deletion mutants as the most effective molar ratio remains 
unchanged after the deletions. 
The potential of HisHSP20 as an inhibitor of undesirable protein aggregation 
merits further study of this protein.  Because the multimeric nature was altered but not 
abolished by the deletions constructed in the previous chapters, further study through site 
specific deletions of the protein around the α-crystallin domain should be performed in 
an effort to produce a form only capable of dimerization.  The activity of this form 
should then be tested as described above.  More structural knowledge of HSP20 would 
give researchers more information on potential models for inhibition of aggregation.  An 
X-ray crystal structure of HSP20 does not exist but is currently underway.  This will 
prove invaluable to understanding the mechanism by which HSP20 inhibits aggregation 
as few α-crystallins have been crystallized.   
Santhoshkumar et al. described the peptide they used to inhibit amyloid fibril 
formation as “mini-α-crystallin”.  This peptide of 19 amino acids is based on a small 
portion of the α-crystallin domain (80).  There is a possibility that such a small region 
from HSP20 could inhibit amyloidogenesis or other protein aggregation.  Extensive 
studies have been performed by others on crucial residues of other α-crystallins (such as 
Arginine 120 in human αB-crystallin) (6, 10).  Point mutational analysis of the 
corresponding residues in HSP20 should also be performed to determine the importance 
of the residues to the specific activities observed in HSP20. 
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Many proteins have been shown to form amyloid such as human apolipoprotein 
C II (apoC2) (34).  Hatters et al. showed that α-crystallin isolated from bovine eye 
lenses inhibited amyloid fibril formation by apoC2 at substoichiometric amounts.  The 
ability of HSP20 to inhibit amyloidogenesis of other proteins should be evaluated.  The 
use of the “amyloid-specific dyes” Congo red and thioflavin T is a relatively simple and 
indirect method of analyzing amyloid fibril formation.  The specificity and quantitative 
nature of these dyes is the subject of debate (81).   To gain a better understanding of how 
HSP20 is interacting with amyloid precursors, other methods such as mass spectrometry 
and circular dichroism should be employed in an effort to study interactions between 
substrate and HSP20 over time.  Finally, an animal model of an amyloidosis should be 
used in testing the efficacy of HSP20 against fibril formation in an in vivo setting.  
Research by Lee and Carson show that HisHSP20 is capable of decreasing cell death of 
neuronal cells in culture when exposed to Aβ(1-40) (27). 
From a therapeutic standpoint, HSP20 holds a large potential.  The fact that the 
protein inhibits amyloidogenesis in sub-stoichiometric amount is desirable as this means 
a much lower dosage to the patient.  Also, there is the possibility that even more of the 
protein can be deleted without an apparent loss of function.  A smaller protein would 
likely have fewer interactions with the host systems.  As we learn more about its 
structure, at the very least, HSP20 can serve as a model in designing and constructing 
more effective treatments against amyloidogenesis.  In a more general application, 
HSP20 is a very good candidate for acting as a preservative element for molecules that 
aggregate in solution or have short shelf lives such as restriction endonucleases and other 
enzymes. 
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In conclusion, we present an interesting and unique protein isolated from a 
protozoan erythrocyte parasite Babesia bovis.  HSP20 exhibits many similarities to 
members of the α-crystallin family in both structure and activities and it is proposed here 
that the protein is indeed a small heat shock protein and should be classified as an α-
crystallin.  The protein has an α-crystallin domain identified by sequence homology with 
known α-crystallins.  HSP20 exists as a polydisperse population of multimeric species in 
solution.  The protein was shown to inhibit thermally induced aggregation of ADH in 
solution and to inhibit amyloidogenesis of the Aβ(1-40) peptide.  Deletions were made in 
the regions of the protein thought to be responsible for multimerization resulting in a 
dramatic reduction in multimeric species.  The deletion mutants constructed were 
designed as to not affect the α-crystallin domain in an effort to only affect 
multimerization and not affect activity.  The deletion mutants exhibited the same levels 
of inhibition of aggregation of proteins as the full-length form of the protein. 
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